TWI333420B - Vapor fraction from seeds of glycine max (l.) merr. and composition thereof - Google Patents

Vapor fraction from seeds of glycine max (l.) merr. and composition thereof Download PDF

Info

Publication number
TWI333420B
TWI333420B TW092122224A TW92122224A TWI333420B TW I333420 B TWI333420 B TW I333420B TW 092122224 A TW092122224 A TW 092122224A TW 92122224 A TW92122224 A TW 92122224A TW I333420 B TWI333420 B TW I333420B
Authority
TW
Taiwan
Prior art keywords
skin
composition
minutes
vapor fraction
wound
Prior art date
Application number
TW092122224A
Other languages
Chinese (zh)
Other versions
TW200505466A (en
Inventor
I Hung Chu
Original Assignee
I Hung Chu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I Hung Chu filed Critical I Hung Chu
Priority to TW092122224A priority Critical patent/TWI333420B/en
Priority to KR1020040063087A priority patent/KR101284071B1/en
Publication of TW200505466A publication Critical patent/TW200505466A/en
Application granted granted Critical
Publication of TWI333420B publication Critical patent/TWI333420B/en
Priority to KR1020110040816A priority patent/KR101220124B1/en
Priority to KR1020120056185A priority patent/KR101252023B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Description

1333420 玖、發明說明: 【發明所屬之技術領域】 本發明王要係關於自大豆(G/>;e/ne繼(L ) 乂⑽)種予 獲得之蒸氣分館物,其具有治療皮膚損傷、治療皮膚病、 刺激細胞再生及刺激毛髮生長之作用。 【先前技術】 大豆(wa;c (L.) Merr )包含大豆及黑豆其為世 界上最重要的油及蛋白質來源之一。舉例而言,大豆可加 工成·含一可食用半乾燥之油,其可用作沙拉油或用於製造 人造奶油及酥油。大豆油亦用於製造塗料、油氈、油布、 油墨、肥皂、殺蟲劑及消毒劑。此外,自油料工業之副產 品中獲得之卵磷脂磷酯可用作食品、化妝品、藥物、皮革、 塗料、塑料、肥宫及清潔劑中之濕潤劑及穩定劑。大豆粉 係一富含蛋白質之家畜用飼料。另外,大豆蛋白可用於製 造合成纖維' 黏合劑、織物上漿、防水、滅火泡沫等。 在醫學使用上,已報導大豆對許多疾病有作用。 大旦可用作一調節腸、心臟、腎、肝及胃之功能之營養 f斗加物由於大旦油含有大量不飽和脂肪酸,故其可用 于對烷咼膽固醇血症。自大豆獲得之醫用卵磷脂可作為一 抗脂肪肝劑。另外,吾人已知作為一抗硬化因子之江類固 醇及作為某些抗高血壓藥中薯蕷皂苷元之替代物之穀固醇 可自大豆製備。自大豆中發現之異黃酮及植物_雌激素已表 明對包含乳癌、前列腺癌及結腸癌在内的各種癌症具有預 防作用’參見「植物,激素及癌症」(AdlercreuU,Η ;1333420 玖, the invention description: [Technical field to which the invention pertains] The present invention relates to a vapor component obtained from soybean (G/>;e/ne followed by (L) 乂(10)), which has a treatment for skin damage It treats skin diseases, stimulates cell regeneration and stimulates hair growth. [Prior Art] Soybean (wa; c (L.) Merr) contains soybeans and black beans, which are among the world's most important sources of oil and protein. For example, soy can be processed into an edible semi-drying oil which can be used as a salad oil or as a margarine and ghee. Soybean oil is also used in the manufacture of coatings, linoleum, tarpaulins, inks, soaps, insecticides and disinfectants. In addition, lecithin phosphate obtained from by-products of the oil industry can be used as a wetting agent and stabilizer in foods, cosmetics, pharmaceuticals, leathers, paints, plastics, fertilizers and detergents. Soy flour is a protein-rich feed for livestock. In addition, soy protein can be used to make synthetic fiber 'adhesives, fabric sizing, waterproofing, fire fighting foam, and the like. In medical use, soybean has been reported to have an effect on many diseases. Large Dan can be used as a nutrient for regulating the function of the intestines, heart, kidneys, liver and stomach. Since large oil contains a large amount of unsaturated fatty acids, it can be used for paraoxane cholesterol. The medical lecithin obtained from soybean can be used as an anti-fatty liver agent. In addition, it is known that a steroid as a primary anti-hardening factor and a sterol which is a substitute for diosgenin in some antihypertensive drugs can be prepared from soybean. Isoflavones and plant-estrogens found in soybeans have been shown to prevent various cancers including breast, prostate and colon cancers. See "Plants, Hormones and Cancer" (AdlercreuU, Η;

ΟΛ83\83756 DOC 1333420ΟΛ83\83756 DOC 1333420

Phyto-oestrogens and cancer. The Lancet Oncology, 2002 » Vol_ 3 ’ p· 364-3 73 ) ?吾人亦發現,食用經添加植物固醇之 人造奶油可降低中老年高膽固醇血症個體中之總血漿膽固 醇及LDL-膽固醇之濃度,參見「每曰食用一劑添加大豆植 物固醇之絞細牛肉可降低男性中青年高膽固醇血症患者之 血清總膽固醇及LDL膽固醇」(Matvienko, 〇. A.,Lewis,D. S., Swanson, M., Aendt, B., Rainwater, D. L., Stewart, J., 及 Aleke1,D· L.; A Single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men. dw A/^r·,2002, 76, p. 57-64 )。 某些大豆萃取物亦經報導具有醫藥作用。取自棕色大豆 變種(Akita-Zairai)種皮之70%含水丙酮萃取物之i,i-二 苯基-2-三硝基苯肼(DPPH )游離基清除活性揭示於「棕色 大豆種皮中具有高游離基清除活性之高聚合矢車菊苷配 焦」(Takahata. Y.,〇_-Kameyama,M_,Furuta,S·, Takahashi, 及 Μ.,Suda, I.; Highly polymerized procyanidins in brown soybean seed coat with a high radical-scavenging activity. J. Jgric. F⑽d C/iew·,2001,49, p. 5843-5847 )。頃發現,取自 胚芽萃取物、大旦、米糠、tear草、芝麻、小麥、香橡、 綠茶、綠葉萃取物及發芽的稻縠之萃取物,在低於6〇。(:下 經一電烘壚緩慢烘烤並使用米麯黴發酵3天以上,以將每 一組分轉化為低分子量物質後可具有抗氧化作用,參見「經 加工穀類食品之抗氧化作用」(Minamiyama,Y.,Yoshikawa, O:\83\83756.DOC -6- 1333420 T·,Tanigawa,T·,Takahashi, S·,Naito,Y.,Ichikawa,Η.及Phyto-oestrogens and cancer. The Lancet Oncology, 2002 » Vol_ 3 ' p· 364-3 73 ) ? We also found that the consumption of phyto-taste with phyto-male can reduce total plasma cholesterol in middle-aged and elderly patients with hypercholesterolemia And the concentration of LDL-cholesterol, see "Eating a dose of soy phytosterol-added ground beef to reduce serum total cholesterol and LDL cholesterol in male and young hypercholesterolemia patients" (Matvienko, 〇. A., Lewis) , DS, Swanson, M., Aendt, B., Rainwater, DL, Stewart, J., and Aleke1, D. L.; A Single daily dose of soybean phytosterols in ground beef, serum total cholesterol and LDL cholesterol in young, Mildly hypercholesterolemic men. dw A/^r·, 2002, 76, p. 57-64). Certain soy extracts have also been reported to have a pharmaceutical effect. The i,i-diphenyl-2-trinitrophenylhydrazine (DPPH) free radical scavenging activity from the 70% aqueous acetone extract of the brown soybean variety (Akita-Zairai) seed coat is revealed in "the brown soybean seed coat has a high Highly polymerized procyanidins in brown soybean seed coat with high free radical scavenging activity (Takahata. Y., 〇_-Kameyama, M_, Furuta, S·, Takahashi, and Μ., Suda, I.; a high radical-scavenging activity. J. Jgric. F(10)d C/iew·, 2001, 49, p. 5843-5847). It was found that extracts from germ extract, large denier, rice bran, tear grass, sesame, wheat, fragrant oak, green tea, green leaf extract and germinated rice bran were below 6 〇. (: After an electric baking, slowly baking and using Aspergillus oryzae for more than 3 days to fertilize each component into a low molecular weight substance, it can have an antioxidant effect, see "Antioxidant effect of processed cereals" ( Minamiyama, Y., Yoshikawa, O:\83\83756.DOC -6- 1333420 T·, Tanigawa, T·, Takahashi, S·, Naito, Y., Ichikawa, Η.

Kondo, M.; Antioxidative effects of a processed grain food. /·施卜· Sci. i994, 49;·泛:#6W7).J 胡蘿蔔、十 . __ _ ' . . *· 字花科植物及包含黑豆、紅豆、綠豆與大豆在内之豆類之 • ; · · - · 練葉煮沸萃取物表明具有很強的抗瘙促進劑及游離基清除 活性,參見「脂過氧化物游離基與腫瘤-促進劑效應間之高 度相關性:各種植物萃取物對EB病毒/B -淋巴細胞系統中 腫瘤增生之抑制及對烷基過氧化物游離基之清除」(Maeda.Kondo, M.; Antioxidative effects of a processed grain food. /·Sb·Sci. i994, 49;·Pan: #6W7).J Carrot, X. __ _ ' . . *· Words of flowers and black beans Beans including red beans, mung beans and soybeans; · · · · Leaf boiling extracts have strong anti-caries promoter and free radical scavenging activity, see "lipid peroxide free radicals and tumor-promoters High correlation between effects: inhibition of tumor proliferation in EBV/B-lymphocyte systems by various plant extracts and removal of alkyl peroxide free radicals" (Maeda.

Η.,Katsuki,T·,Akaike,Τ·及 Yasutake. R.; High correlation between lipid peroxide radical and tumor-promoter effect: suppression of tumor promotion in the Epstein-Barr virus/B-lymphocyte system and scavenging of alkyl peroxide radicals by various vegetable extracts. Jpn. J. Cancer Res., 1 992,83,p. 923-928 )。藉由量測大鼠中血清穀胺酸-草酸_ 轉胺酶(sGOT)及血清縠胺酸-丙酮酸_轉胺酶(sGPT)之Correlation.,Katsuki,T·,Akaike,Τ· and Yasutake. R.; High correlation between lipid radical and tumor-promoter effect: suppression of tumor promotion in the Epstein-Barr virus/B-lymphocyte system and scavenging of alkyl peroxide Radicals by various vegetable extracts. Jpn. J. Cancer Res., 1 992, 83, p. 923-928). By measuring serum glutamate-oxalic acid-transaminase (sGOT) and serum proline-pyruvate-transaminase (sGPT) in rats

活性,黑豆之水萃取物亦顯示對由乙醯胺基酚引發之肝病 有作用’參見「對豆科植物之肝保護活性之評價」(Wu,S.-J.,The active, black bean water extract also showed an effect on liver disease caused by acetaminophen ‘see “Evaluation of hepatoprotective activity against legumes” (Wu, S.-J.,

Wang, J.-S.及 Chang C.-H·; Evaluation of hepatoprotective activity of legumes. Phytomedicine, 2001, V〇l. 8(3), p. 2 1 3-2 1 9 ) °使用一由低脂族醇及低沸點酯之混合系統組成 之萃取液獲得之大豆種子萃取物顯示為一飲料製劑(日本 專利第1 117767號)。 頃發現,某些特定的大豆萃取物可用於治療某些皮膚病 之化妝品或藥物中。Wang, J.-S. and Chang C.-H·; Evaluation of hepatoprotective activity of legumes. Phytomedicine, 2001, V〇l. 8(3), p. 2 1 3-2 1 9 ) ° A soybean seed extract obtained by an extract composed of a mixed system of an aliphatic alcohol and a low-boiling ester ester is shown as a beverage preparation (Japanese Patent No. 1 117767). It has been found that certain specific soy extracts can be used in cosmetics or medicines for the treatment of certain skin conditions.

O:\83\83756 DOC 1333420 含有規定比率之鞘磷脂及磷脂之大豆萃取物經揭示可用 於治療乾性皮膚之化妝品中(美國專利公開案第 US2002/00095 09 A1號)。該等萃取物可藉由單獨使用脂族 醇或其與水之混合物萃取成熟之完整大豆或無油大豆粉產 生,且隨後使用脂族烴及脂族酮處理。故,該萃取物是脂 溶性的。O: \83\83756 DOC 1333420 A soy extract containing a predetermined ratio of sphingomyelin and phospholipids is disclosed for use in the treatment of dry skin cosmetics (U.S. Patent Publication No. US 2002/00095 09 A1). These extracts can be produced by extracting mature whole soybean or oil-free soy flour using an aliphatic alcohol alone or a mixture thereof with water, and then treating with an aliphatic hydrocarbon and an aliphatic ketone. Therefore, the extract is fat-soluble.

頃發現,一含有一或多種植物萃取物(其係選自乳清、 及一黃柏萃取物,及進一步選自黃岑、西門肺草及大豆 (G/少wax (L.) Merrill )之一或多種萃取物)之化妝品 組合物、粉刺藥、或黑頭粉刺生成抑制劑對預防或治療皮 膚病(例如粉刺或由粉刺引起之發炎被裂皮膚)有效(日 本專利第2001097842號)。該組合物可用于製造普通飲料、 食物及諸如此類。It has been found that one contains one or more plant extracts selected from the group consisting of whey, and a cortex extract, and further selected from the group consisting of scutellaria, sage, and soybean (G/less wax (L.) Merrill) The cosmetic composition, the acne medicine, or the blackhead acne production inhibitor of the various extracts is effective for preventing or treating a skin disease such as acne or irritated skin caused by acne (Japanese Patent No. 2001097842). The composition can be used to make regular beverages, foods, and the like.

皆,舉例而言,丙二醯基異黃酮普等,可作為一上皮細胞 增生促進劑(日本專利第9〇59166號)。該酷苷藉由下述步 驟獲得:# 45-65。(: 了將去皮大豆浸入用苛性麵調節至 PH7·5至ρΗ9·0之水巾2·4小時,去除大^得到浸潰水作 為水萃取液’使用-超滤膜自萃取液中去除蛋白以得到一 濾出液,使該濾出液與一吸附劑接觸且藉由使用一醇之水 溶液或-醇之驗性水溶液自吸附物f中洗脫出醣苦。7 使用微生物發酵大豆之產物亦可 ,,用作抗,舌性虱作用組入 物、試劑、食品、化妝品及藥品( ° 號)。 、例如日本專利第4139132For example, propylene glycol isoflavones can be used as an epithelial cell proliferation promoting agent (Japanese Patent No. 9〇59166). This glucoside was obtained by the following procedure: #45-65. (: The diced soybean was immersed in a water towel adjusted to pH 7·5 to ρΗ9·0 with a caustic surface for 2.4 hours, and the large water was removed to obtain the water extract as the water extract 'Using the ultrafiltration membrane to remove from the extract The protein is obtained as a filtrate, and the filtrate is contacted with an adsorbent and the sugar bitter is eluted from the adsorbent f by using an aqueous solution of an alcohol or an aqueous solution of an alcohol. The product can also be used as an anti-, lingual sputum group, reagent, food, cosmetics and medicine (°). For example, Japanese Patent No. 4139132

O:\83\83756.DOC 1333420 然而,並無先前技藝給出或闡明易於製備之大豆( 所a (L.) Merr·)之低濃度醇或無醇之蒸氣分餾物在治療皮 膚損傷及皮膚病方面之用途。 【發明内容】 本發明提供一自大且(max (L.) Merr.)種子獲得 义詻氣分餾物,其對治療皮膚損傷、治療皮膚病、刺激細 胞再生及刺激毛髮生長有顯著作用。 本發明之蒸氣分餾物藉由一包含下述步驟之方法製備: (a) 提供種子在一醇溶液(其含有濃度低於約i5 % wt 之醇)或水中之粗萃物;及 (b) 在大氣壓力低於約1 atm且溫度低於約11 〇。匚下蒸發 粗萃物以獲得蒸氣分餾物。 該蒸氣分餾物不同於任何已知之大豆(G/少所以(L ) Merr.)種子萃取物,乃因其透過高效液相層析()之 指紋顯示為一獨特的描繪圖形。具體而言,使用内徑(丨D ) 為4.6毫米、長度(L)為25〇毫米且顆粒大小為5微米之 Waters Sphers〇rbTM-〇DS2管柱于20〇奈米波長取得之5〇 微升蒸氣分館物之HPLC圖ΐ醬包括偏離係數為8 %且遲滯時 間為2.910、5.190、13.190及50.815分鐘之峰值,其中流 動相在0至5分鐘為95% Η20/5°/❶CH3CN,在5至30分 鐘之梯度為95% H20/5%CH3CN,在30至80分鐘之梯度 為75% H20/25% CH3CN,在80至1〇〇分鐘之梯度為〇% H2〇/l〇〇% CH3CN,在1〇〇至丨〇1分鐘之梯度為〇% H20/1〇〇% CH3CN’ 且在 101 分鐘為 95% H2〇/5% CH3CN ;O:\83\83756.DOC 1333420 However, there is no prior art to give or clarify the low-concentration alcohol or alcohol-free vapor fraction of soybeans (a (L.) Merr·) that are easy to prepare for the treatment of skin damage and skin. The use of the disease. SUMMARY OF THE INVENTION The present invention provides a smectic (max (L.) Merr.) seed to obtain a scorpion gas fraction which has a significant effect on treating skin damage, treating skin diseases, stimulating cell regeneration, and stimulating hair growth. The vapor fraction of the present invention is prepared by a process comprising the steps of: (a) providing a crude extract of the seed in an alcohol solution (containing an alcohol having a concentration of less than about i5% by weight) or water; and (b) At atmospheric pressures below about 1 atm and temperatures below about 11 〇. The crude extract is evaporated under the underarm to obtain a vapor fraction. This vapor fraction is different from any known soy (G/L (M) Merr.) seed extract because it is displayed as a unique graphic by high performance liquid chromatography () fingerprinting. Specifically, a Waters Sphers 〇rbTM-〇DS2 column having an inner diameter (丨D) of 4.6 mm, a length (L) of 25 mm, and a particle size of 5 μm was obtained at a wavelength of 20 〇 nanometers. The HPLC chart of the sulphur vapor column includes a deviation coefficient of 8% and a hysteresis time of 2.910, 5.190, 13.190 and 50.815 minutes, wherein the mobile phase is 95% 020/5°/❶CH3CN at 0 to 5 minutes, at 5 The gradient to 30 minutes is 95% H20/5% CH3CN, the gradient from 30 to 80 minutes is 75% H20/25% CH3CN, and the gradient at 80 to 1 minute is 〇% H2〇/l〇〇% CH3CN The gradient from 1 〇〇 to 1 minute is 〇% H20/1〇〇% CH3CN' and 95% H2〇/5% CH3CN at 101 minutes;

ΟΛ83\83756 〇〇C 1333420 且流速為1毫升/分鐘。 本發明亦提供一包含本發明之蒸氣分餾物之組合物。具 體而言,該組合物可用於一醫藥组合物、化妝品组合物或 皮膚清潔組合物。 【實施方式】 根據本發明,吾人出乎意料地發現大豆(少所似(L)ΟΛ83\83756 〇〇C 1333420 and the flow rate is 1 ml/min. The invention also provides a composition comprising the vapor fraction of the invention. In particular, the composition can be used in a pharmaceutical composition, a cosmetic composition or a skin cleansing composition. [Embodiment] According to the present invention, we have unexpectedly discovered soybeans (Likely like (L)

Men·.)〈咨氣分館物對治療皮膚損傷、治療皮膚病、刺激 細胞再生及刺激毛髮生長有顯著作用。 根據本發明,一自大豆(咖—㈣;c (L.) Meir.)種子獲 知 < 洛氣分餾物藉由包含下述步驟之方法製備: (a) 提供一種子在醇溶液(其含有濃度低於約i5 % w 之醇)或水中之粗萃物;及 (b) 在大氣壓力低於約i _且溫度低於約下蒸發Men·.) The Qiqi Branch has a significant effect on the treatment of skin damage, treatment of skin diseases, stimulation of cell regeneration and stimulation of hair growth. According to the present invention, a seed from soybean (ca-(4); c (L.) Meir.) is known to be produced by a method comprising the following steps: (a) providing a solution in an alcohol solution (which contains a concentration of less than about i5 % w of alcohol or a crude extract in water; and (b) evaporation at atmospheric pressure below about i _ and at a temperature below about

該粗萃物以獲得蒸氣分餾物。 …X 吾人出乎意料地發現自種子在一醇溶液(其含有濃度 於約% wt之醇)或水中之粗萃物獲得之蒸氣分餘二 在皮膚病學方面具有作用。該蒸氣分餾物易於製備。自 豆(咖⑻wgML·) Merr.)種子製備藥品或化莊品很 利’乃因:⑴大豆可長期食用且據信為無毒性;及(2 大豆價格低廉。 大豆(_ (L ) 醇落液(其含有濃度低於 ,項技藝中通常用來自植 可用于實施本發明。舉例 在本發明之一具體實施例中, Merr.)種子之粗萃物藉由使用— 約1 5% wt之醇)或水萃取獲得。 物種子獲得粗萃物之任何方法均 O:\83\837J6.DOC -10- 1333420 而言’該粗萃物可藉由任何習知方法,例如研磨'揽拌、 擾動、切割或切碎方法將種子分成碎塊並將其浸沒在一濃 度低於·勺1 5 /〇 wt之醇溶液中來獲得。在_較佳具體實施例 中醇/辰度為低於約丨〇% wt,更佳為低於約㈣或約 wt根據本發明,該粗萃物亦可用水萃取。在一較佳具體 實施例中,將種子碎塊浸沒於按重量計介於約5%至約10% 把圍中《醇或水中。此項技藝中通常用來分割種子及萃取 該已分割種子之任何方式均可用于實施本發明。 根據本發月,遠粗萃物在大氣塵·力低於約1 atm且溫度 低於約U〇°C(較佳介於約60。(:至約11〇。〇下受到蒸發。 該蒸氣分餾物可藉由冷卻該蒸氣以液體形式收集。 在本發明之一較佳具體實施例中,在一給定大氣壓力及 /m度下洛發孩粗萃物且藉由冷卻蒸氣收集該蒸氣分餾物之 方法可在一旋轉蒸發器中實施,其中蒸氣被蒸發至供有冷 水之冷凝管中,並隨後使該蒸氣通過該冷凝管冷卻且以液 體形式收集該蒸氣分餾物。該作業簡單且成本低廉。 根據本發明之蒸氣分餾物可使用高效液相層析(HPLC ) 分析及鑑疋。舉例而言,使用内徑(I.D.)為4.6毫米、長 度(L)為250毫米且顆粒大小為5微米之Waters SpherS〇rbTM-〇DS2管柱于200奈米波長取得之50微升蒸氣 分館物之HPLC圖譜包括偏離係數為8%且遲滞時間為 2·91〇、5.190、丨3.19〇及5〇,815分鐘之峰值,其中流動相 在0至5分鐘為95% H20/5% CH3CN ;在5至30分鐘之 梯度為95% H2〇/5%cH3CN,在30至80分鐘之梯度為75 OV83\83756.doc -11- % H2〇/25% CH3CN;在80至100分鐘之梯度為〇% H2O/100% Ch3CN;,在100至1〇1分鐘之梯度為〇% H2O/100% ch3CN,在 101 分鐘為 95% H20/5 % c:H3(:N, 且泥速為1毫升/分鐘。根據該圖譜,蒸氣分餾物中之物質 顯示強極性。其明顯不同於揭示於先前技藝中之其它組 分°舉例而言’黃豆苷原及染料木黃酮之結構中有四個環 且其具有弱極性。 在本發明之一較佳具體實施例中,可加入若干草藥以有 助於大豆(max (L.) Men··)種子治療皮膚損傷治 療皮膚病、刺激細胞再生及刺激毛髮生長。根據本發明, 一洛氣分餾物自含有大豆(所们:(L·) Merr.)種子且 含有至少一種選自由芝麻(ζ·«山.cww )種子、綠p (尸l·)種子及抗菌草藥組成之群中之物 質又原料中獲得。自原料中製備蒸氣分餾物及分析與鑑定 该蒸氣分餾物係如上所述。較佳地,該抗菌草藥係選自由 大黃(L.)的乾根莖、大黃(Rhei Rhiz〇ma) 勺乾根里、育檗()的乾樹皮 及黃柏(Phellodendd Cortex)的乾樹皮組成之群。另一方 面,原料中較佳包含約40%至約100%之大豆(⑺少以…历以 ()err·)種子、0至約50%之芝麻(μ山·c_ ) 種子、0至約50%之綠豆(尸六似印/以L )種子及 〇至約30%之抗菌草藥。 在本發明之一更佳具體實施例中原料中包含約7〇%之 大旦(㈣尤(L·) Merr.)種子、約2〇%之芝麻The crude extract is taken to obtain a vapor fraction. ...X We have unexpectedly found that the vapor fraction obtained from the crude extract of the seed in an alcohol solution (which contains an alcohol in a concentration of about % wt) or in water has a dermatological effect. This vapor fraction is easy to prepare. From beans (Cai (8) wgML·) Merr.) Seed preparation medicines or chemical products are very profitable. '(1) Soybeans can be eaten for a long time and are believed to be non-toxic; and (2 soybeans are inexpensive. Soy (_ (L) alcohol The liquid (which contains a concentration lower than that commonly used in the art, can be used to practice the invention. For example, in one embodiment of the invention, Merr.) the crude extract of the seed is used - about 5% wt Obtained by alcohol or water extraction. Any method for obtaining a crude extract of the seed is O:\83\837J6.DOC -10- 1333420 For the sake of 'the crude extract can be mixed by any conventional method, such as grinding' The perturbation, cutting or chopping method divides the seed into pieces and immerses it in an alcohol solution having a concentration lower than 1 sc / 15 wt. In a preferred embodiment, the alcohol/minus is lower than About 5% by weight, more preferably less than about (four) or about wt. According to the invention, the crude extract may also be extracted with water. In a preferred embodiment, the seed pieces are immersed in by weight. 5% to about 10% of the "alcohol or water." This technique is commonly used to separate seeds and extract the divided seeds. Any of the ways can be used to practice the invention. According to this month, the far coarse extract has an atmospheric dust force of less than about 1 atm and a temperature of less than about U 〇 ° C (preferably between about 60. (: to about 11) The underarm is vaporized. The vapor fraction can be collected in liquid form by cooling the vapor. In a preferred embodiment of the invention, the hair is raised at a given atmospheric pressure and /m degrees And collecting the vapor fraction by cooling vapor can be carried out in a rotary evaporator, wherein the vapor is evaporated into a condenser provided with cold water, and then the vapor is cooled through the condenser and collected in liquid form The steam fraction is simple and inexpensive. The vapor fraction according to the present invention can be analyzed and evaluated by high performance liquid chromatography (HPLC). For example, an inner diameter (ID) of 4.6 mm and a length are used. L) The HPLC profile of a 50 μl vapor fraction of a Waters SpherS〇rbTM-〇DS2 column of 250 mm and a particle size of 5 μm at a wavelength of 200 nm includes a deviation factor of 8% and a hysteresis time of 2· 91〇, 5.190, 丨3.19〇 and 5〇, 815 Peak of the peak, where the mobile phase is 95% H20/5% CH3CN for 0 to 5 minutes; 95% H2〇/5% cH3CN for a gradient of 5 to 30 minutes, 75 OV83\83756 for a gradient of 30 to 80 minutes .doc -11- % H2〇/25% CH3CN; the gradient at 80 to 100 minutes is 〇% H2O/100% Ch3CN; the gradient at 100 to 1〇1 minute is 〇% H2O/100% ch3CN, at 101 The minutes are 95% H20/5 % c:H3 (:N, and the mud speed is 1 ml/min. According to the map, the substance in the vapor fraction shows a strong polarity. It differs significantly from the other components disclosed in the prior art. For example, there are four rings in the structure of daidzein and genistein which have a weak polarity. In a preferred embodiment of the invention, several herbs may be added to aid in the treatment of skin lesions, stimulating cell regeneration and stimulating hair growth by treating soybean (max (L.) Men··) seeds. According to the present invention, a gas fraction is self-contained with soybean seeds and contains at least one seed selected from the group consisting of sesame seeds, green p (corpse l·) seeds, and The substances in the group consisting of antibacterial herbs are obtained from raw materials. Preparation of Vapor Fraction from Raw Material and Analysis and Identification The vapor fraction is as described above. Preferably, the antibacterial herb is selected from the group consisting of dried rhizome of rhubarb (L.), dried root of Rhei Rhiz〇ma, dried bark of oyster (), and dried bark of Phellodendd Cortex. Group. On the other hand, the raw material preferably contains from about 40% to about 100% of soybeans ((7) less than ... err) seed, 0 to about 50% of sesame (μ山·c_) seeds, 0 to about 50% of mung beans (corpse six prints / L) seeds and sputum to about 30% of antibacterial herbs. In a more preferred embodiment of the invention, the raw material comprises about 7% of the large denier ((4) Eu (.) Merc.) seeds, about 2% of the sesame seeds.

0\83\83756.DOC -12· 1333420 (Sesamumindicum)種子、約 5% 之欠黃(Rheumpalmatum L.)的乾根莖或大黃.(RheiRhizoma)的乾根莖及約5%之 黃檗(Phellodendron amurense Rupr.)的乾樹:皮良责換 (Phellodendri Cortex )的乾樹皮。該原料係在約2%之醇 中。 在本發明之另一更佳具體實施例中,原料中包含約8〇% 之大豆m似(L.) Men*.)種予及約2〇%之綠豆 (以如⑼/⑽μ山L.)種子。該原料係在約2%之醇中。 在本發明之再一更佳具體實施例中,原料中包含約8〇% 之大豆(L.) Meir.)種子及約2〇%之芝麻 (ζ·„山·cww )種子。該原料係在約2%之醇中。 在本發明之另一更佳具體實施例中,原料中包含約90% 之大豆(L_) Men··)種子及約1〇%之大黃 (及办⑼所ζ·)的乾根莖或大黃(Rhei Rhiz〇ma ) 的乾根莖。該原料係在水中β 在本發明之另一更佳具體實施例中,原料中包含約8〇% 之大豆(waML.) Merr )種子、約1〇%之芝麻 (Sesam㈣indic㈣)種子及約1〇%之大黃〔Rhe_ 尸/所aiwm L.)的乾根莖或大黃(Rhei Rhiz〇ma )的乾根莖。 該原料係在水中。 在本發明之最佳具體實施例中,原料中包含約53%之大 旦(⑽e m(n:(L ) Merr )種子約2〇%之芝麻(心5_謂 種予、約之綠豆(尸W▲⑽咖L.)種 子约5%之大黃(Rheum palmatum L )的乾根莖或大黃0\83\83756.DOC -12· 1333420 (Sesamumindicum) seeds, about 5% of Rheumpalmatum L. dried rhizome or rhubarb. (RheiRhizoma) dried rhizome and about 5% of jaundice (Phellodendron amurense Rupr) .) Dry tree: Dry bark of Phellodendri Cortex. This material is in about 2% alcohol. In another preferred embodiment of the present invention, the raw material comprises about 8% of soybeans (L.) Men*.) and about 2% of mung beans (for example, (9) / (10) μ mountain L. )seed. The feedstock is in about 2% alcohol. In still another more preferred embodiment of the present invention, the raw material comprises about 8% by weight of soybean (L.) Meir.) seeds and about 2% by weight of sesame (ζ·„山·cww) seeds. In about 2% of the alcohol. In another preferred embodiment of the invention, the raw material comprises about 90% of soybean (L_) Men··) seeds and about 1% of rhubarb (and office (9) Dry rhizome of rhesus rhubarb or rhubarb (Rhei Rhiz〇ma). The feedstock is in water. In another preferred embodiment of the invention, the feedstock comprises about 8% soy (waML. Merr) seeds, about 1% sesame (Sesam (indicative) (dic)) and dried rhizome of about 1% rhubarb (Rhe_ corpse / aiwm L.) or dried rhizome of rheusia (Rhei Rhiz〇ma). In the preferred embodiment of the present invention, the raw material contains about 53% of large denier ((10)e m(n:(L) Merr) seeds of about 2% by weight of sesame (heart 5_ pre-species, About mung bean (corpse W▲ (10) coffee L.) seeds about 5% of rhubarb (Rheum palmatum L) dry rhizome or rhubarb

ON83\83756.DOC -13- 1333420 (Rhei Rhizoma )的乾辑莖及約 5% 之黃榮( arnwrewe 及wpr.)的乾樹皮或黃柏(PhellodendriCortex)的 乾樹皮。該原料係在約3 %或約2 %之醇中或水中。而且, 使用内徑(I.D.)為4.6毫米、長度(L)為250毫米且顆 粒大小為5微米之Waters SphersorbTM-ODS2管柱于200奈 米波長取得之50微升蒸氣分餾物之HPLC圖譜包括偏離係 數為8%且遲滯時間為2.896、5. m、12.944及46.603分鐘 ‘ 之峰值’其中流動相在〇至5分鐘為95% H20/5% CH3CN, '* 在5至30分鐘之梯度為95% H20/5% CH3CN,在30至80 分鐘之梯度為75% H20/25% CH3CN,在80至100分鐘之 梯度為0% H20/100% CH3CN,在1〇〇至1〇1分鐘之梯度 為 〇% H2O/100% CH3CN,在 101 分鐘為 95% H20/5% CH3CN,且流速為1毫升/分鐘。ON83\83756.DOC -13- 1333420 (Rhei Rhizoma) dry stem and about 5% of the dried bark of arnwrewe and wpr. or the dry bark of PhellodendriCortex. The feedstock is in about 3% or about 2% alcohol or water. Moreover, the HPLC profile of a 50 μl vapor fraction obtained using a Waters SphersorbTM-ODS2 column having an inner diameter (ID) of 4.6 mm, a length (L) of 250 mm and a particle size of 5 μm at a wavelength of 200 nm includes deviation The coefficient is 8% and the lag time is 2.896, 5. m, 12.944 and 46.603 minutes 'peak' where the mobile phase is 95% H20/5% CH3CN in 〇 to 5 minutes, '* gradient in 5 to 30 minutes is 95 % H20/5% CH3CN, gradient from 30 to 80 minutes, 75% H20/25% CH3CN, gradient from 80 to 100 minutes, 0% H20/100% CH3CN, gradient from 1〇〇 to 1〇1 minute It is 〇% H2O/100% CH3CN, 95% H20/5% CH3CN at 101 minutes, and the flow rate is 1 ml/min.

本發明亦提供一含有根據本發明之蒸氣分餾物之組合 物。較佳地,該組合物係選自由—醫藥組合物 '一化妝品 組合物及一皮膚清潔組合物組成之群。在根據本發明之— 較佳具體實施例中,該組合物進—步包含一抗菌製劑,例 如冰片《較佳地’根據本發明之蒸氣分㈣之量介於組合 物總重量之約70%至約80%之間 在本發明之一具體實施例由 % ^中’該組合物進一步包含冰 片、硬脂酸、硬脂醇、棕櫚酸 , ^ Λ 1 ^、十六烷醇、蜂蠟及聚氧伸 乙基去水山梨醇單硬脂酸酯r pr^、 u 0 曰l Ρ〇Ε)以形成一易於施於— 受治療者之軟膏。 之方法包含以一可有效治 用於治療皮膚4貝傷或皮膚病 0'83'83756 D〇c •14- 1333420 療皮膚損傷、治療皮膚_、剌激細胞再生及刺激毛髮生長 之足夠量施用根據本發明之组合物。 根據本發明之蒸氣分餾物可用於治療皮膚損傷、 膚病、刺激細胞再生及刺激毛髮生長。舉例而言,皮膚損 傷或皮膚病包含燒傷、曬傷、輕射傷、急性及慢性、 發斑、皮炎、斑點、丘珍、小結、水皰、大水皰'膿皰、 風疹塊。斑塊、囊腫、鱗屑病、痂、裂隙、溃瘍、粉刺、 皮膚乾燥症、脫皮、瘙癢、變應性濕療、療及毛囊缺損。 較佳地,根據本發明之組合物可有效治療燒傷、輕射傷、 急性及性損傷、皮炎、壞疽、慢性療積性潰癌、擦傷、 特應性皮炎、縫合傷口、糖尿病創傷及毛囊缺損。 在下述動物模型中,已證明根據本發明之蒸氣分铜物對 治療不含肉芽之大面積皮膚缺陷、瘢痕及過敏反應有效。 另外丨亦可冶療毛囊缺損且毛髮可再次生長且不留紅斑 或焦滅。使用根據本發明之蒸氣分館物治療傷口之復原速 度及條件較彼等使用習知藥物治療者更佳。使用根據本發 明<蒸氣分m台療之傷口癒合時無症&,且已癒合傷口 之皮膚顏色與正常皮膚顏色相同。此外,在組織學檢查中, 使用根據本發明之蒸氣分館物治#之傷口之皮膚組織未顯 不通常會引起外觀巨大損傷且需要複雜的重建手術之纖維 變性。 另外,使用本發明之蒸氣分餾物治療之傷口未發現過敏 反應、炎症、膿皰或疹》治療後,傷口之附屬器官及細胞 之生長與彼等正常皮膚中者相同。與之相反,使用一習知 O:\83\83756.DOC •15- 1333420 藥物治療之傷口較正常皮膚具有較少數量之附屬器官及細 胞’且該傷口之纖維寬度更大。 •此卜&據本發明疋蒸氣分餾物可有效治療輻射傷。迄 今為止’尚無可有效治療職傷之藥物。吾人出乎意料地 發現,在-遭受_之受治療者中,使用該蒸氣分館物 治療後之傷口顯示較低之毛髮損傷且無過敏反應。 另外’通常可在傷口癒合時觀察到之炎症與組織攣縮未 出現於使用根據本發明之蒸氣分館物;台療之傷口中。該蒸 氣分餾物可有效治療皮膚受到損傷之傷口。故,本發明提 供了一用於治療大面積及皮膚傷口之較佳、方便且經濟之 方式。 下述實例僅用於闡釋之目的,而非對本發明之範圍加以 限定。 實例1 :大豆(Glycine max (l.) Merr.)種子之蒸氣分餾 物之製備 研磨包έ大i ( G7少che max (L.) Merr.)種子、芝麻 (hAcwm )種子、綠豆(尸Aase〇& •如l.) 種子、大黃(仙eww pa/waiwm L.)的乾根莖或大黃(Rhei Rhizoma )的乾根莖及 s 榮) 的乾樹皮或黃柏(Phell〇dendri Cortex.)的乾樹皮之原料並 使用按重量計8%之醇或蒸餾水萃取之以獲得一粗萃物。其 含量如表1所示。蒸氣分餾物藉由在壓力低於1 atm且溫 度為60〇C下於一旋轉蒸發器(EYELA N-1000S,1000S-W) 内蒸發該粗萃物並使其通過一供有冷水之冷凝管獲得。The invention also provides a composition comprising a vapor fraction according to the invention. Preferably, the composition is selected from the group consisting of - a pharmaceutical composition - a cosmetic composition and a skin cleansing composition. In a preferred embodiment according to the present invention, the composition further comprises an antibacterial preparation, such as borneol. Preferably, the amount of vapor (four) according to the present invention is between about 70% of the total weight of the composition. Between about 80% and a specific embodiment of the invention from %^' the composition further comprises borneol, stearic acid, stearyl alcohol, palmitic acid, ^ Λ 1 ^, cetyl alcohol, beeswax and poly Oxygen extended ethyl sorbitan monostearate r pr^, u 0 曰l Ρ〇Ε) to form an ointment that is easy to apply to the subject. The method comprises administering a sufficient amount of the skin lesion, treating the skin, stimulating cell regeneration and stimulating hair growth, which can be effectively treated for treating 4 skin lesions of the skin or skin diseases 0'83'83756 D〇c • 14-1333420 A composition according to the invention. The vapor fraction according to the present invention can be used to treat skin damage, skin diseases, stimulate cell regeneration, and stimulate hair growth. For example, skin lesions or skin diseases include burns, sunburns, light shots, acute and chronic, erythema, dermatitis, spots, chujin, nodules, blisters, large blisters, pustules, and rubella. Plaque, cyst, scaly, sputum, fissure, ulcer, acne, dry skin, peeling, itching, allergic wet therapy, treatment and hair follicle defects. Preferably, the composition according to the present invention is effective for treating burns, light shots, acute and sexual injuries, dermatitis, gangrene, chronic therapeutic ulceration, abrasions, atopic dermatitis, suture wounds, diabetic wounds and hair follicle defects. . In the animal model described below, it has been demonstrated that the vaporous copper component according to the present invention is effective for treating large areas of skin defects, scars and allergic reactions without granulation. In addition, the hair follicle defect can be treated and the hair can grow again without leaving erythema or burnout. The speed and condition of healing of wounds treated with the vapor sub-sector according to the present invention are better than those of the conventional medical treatments. When the wound is healed according to the present invention <vaporation, the skin color of the wound has been the same as that of the normal skin. Further, in the histological examination, the use of the skin tissue of the wound according to the present invention does not significantly cause the appearance of a large damage and requires complicated reconstruction surgery for fiber denaturation. Further, after the treatment of the wound treated with the vapor fraction of the present invention, no allergic reaction, inflammation, pustule or rash was observed, and the growth of the accessory organs and cells of the wound was the same as that in the normal skin. In contrast, a conventionally treated O:\83\83756.DOC •15-1333420 medically treated wound has a smaller number of accessory organs and cells than normal skin and the wound has a greater fiber width. • This & 疋Vapor fractionation according to the invention is effective in treating radiation injuries. So far, there are no drugs that can effectively treat occupational injuries. We have unexpectedly found that in the treated subjects, the wounds treated with the vapor branch showed lower hair damage and no allergic reactions. Further, inflammation and tissue contracture which are usually observed when the wound is healed are not present in the wound using the vaporous branch according to the present invention; The vapor fraction is effective for treating wounds with damaged skin. Thus, the present invention provides a preferred, convenient and economical means for treating large areas and skin wounds. The following examples are for illustrative purposes only and are not intended to limit the scope of the invention. Example 1: Preparation of Soybean (Glycine max (l.) Merr.) Seed Vapor Fractions Grinding Packings i (G7 less che max (L.) Merr.) seeds, sesame (hAcwm) seeds, mung beans (corpse Aase) 〇& •L.) l.) dried rhizome of seeds, rhubarb (Rose eww pa/waiwm L.) or dried rhizome of rhubarb (Rhei Rhizoma) and dried bark or Phellodendron (Phell〇dendri Cortex.) The raw material of the dried bark is extracted with 8% by weight of alcohol or distilled water to obtain a crude extract. Its content is shown in Table 1. The vapor fraction is evaporated in a rotary evaporator (EYELA N-1000S, 1000 S-W) at a pressure of less than 1 atm and at a temperature of 60 ° C and passed through a condenser provided with cold water. obtain.

〇 \83\83756 DOC -16· 1333420 表1 原 料 分館物號 '1 2 3 4 5 6 7 8 大豆(max (L,) Merr.) 種子(%) 100 70 53 80 0 80 90 80 芝!^ ( Sesamum indicum)種 子(%) 0 20 20 0 0 20 0 10 (Phaseolus radiatus L·) 種子(%) 0 0 17 20 0 0 0 0 大黃(Rheumpalmatum L·) 的乾根莖或大黃(Rhei Rhizoma)的乾根莖(。/〇) 0 5 5 0 0 0 10 10 专:藥l iPhellodendron amwr饥的乾樹皮或 黃柏(Phellodendri Cortex) 的乾樹皮(%) 0 5 5 0 0 0 0 0 溶液 蒸餾水(%) 98 98 98 98 100 98 100 100" 醇(%) 2 2 2 2 0 2 0 0 50微升分餾物1之HPLC結果如圖1所示。該HPLC藉 由使用内徑(I.D.)為4·6毫米、長度(L)為250毫米且 顆粒大小為5微米之Waters SphersorbTM-ODS2管柱實施, 其中流動相在0至5分鐘為95% H20/5% CH3CN,在5至 30分鐘之梯度為95% H20/5% CH3CN,在30至80分鐘之 梯度為75% H20/25% CH3CN,在80至100分鐘之梯度為 0% H20/100% CH3CN,在1〇〇至1〇1分鐘之梯度為〇% H20/100% CH3CN ’ 在 1〇1 分鐘為 95% H20/5% CH3CN, 且流速為1毫升/分鐘。該HPLC使用Waters Alliance 2795 HT實施,且該圖譜使用Waters Photo Diode Array (光電二 極體陣列)2996於190至400奈米波長取得。如于200奈 米波長取得之圖譜所示’在偏離係數為8%且遲滯時間為 2.910、5.190、13.190 及 50.815 分鐘時存在尖辛。 〇 \83\83756 DOC -17· 1333420 50微升分餾物3之HPLC結果如圖2所示。該HPLC藉 \ 由使用内徑(I.D.)、為4.6毫米、長度(L)為250毫米且 顆粒大小為5微米之Waters SphersorbTM-ODS2管柱實施, 其中流動相在0至5分鐘為95% H20/5% CH3CN,在5至 3〇分鐘之梯度為95% H20/5% CH3CN,在30至80分鐘之 梯度為75%H20/25% CH3CN,在80至100分鐘之梯度為〇 % H20/1〇〇% CH3CN,在100至101分鐘之梯度為〇% H2〇/i〇〇% CH3CN,在 101 分鐘為 95% H20/5% CH3CN, 且流速為1毫升/分鐘。該HPLC使用Waters Alliance 2795 HT貫施,且該圖譜使用waters Photo Diode Array (光電二 極體陣列)2996於190至400奈米波長取得。如于200奈 米波長取得之圖譜所示,在偏離係數為8 %且遲滞時間為 2·896、5.111、12.944 及 46.603 分鐘時存在尖峰。 實例2:軟膏之製備 根據本發明之軟膏如表2之例示: 表2 含量(wt) 分掏物 Τ7~%~ 冰片 0.6 % _硬脂酸 5 % -_硬脂醇 4 % __棕搁酸 4 % — 十六燒醇 5 % 蜂蠟 2 % 系氧伸乙基去水山梨 醇單硬脂酸酯 2.4 % 本發明之軟膏可使用此項技藝中通常所用之任何習知方〇\83\83756 DOC -16· 1333420 Table 1 Raw material branch number '1 2 3 4 5 6 7 8 Soybean (max (L,) Merr.) Seed (%) 100 70 53 80 0 80 90 80 Chiba!^ (Sesamum indicum) Seed (%) 0 20 20 0 0 20 0 10 (Phaseolus radiatus L·) Seed (%) 0 0 17 20 0 0 0 0 Rhubarb (Rheumpalmatum L·) of dried rhizome or rhubarb (Rhei Rhizoma Dried rhizome (./〇) 0 5 5 0 0 0 10 10 Special: medicine l iPhellodendron amwr hunger dry bark or dried bark of Phellodendri Cortex (%) 0 5 5 0 0 0 0 0 solution distilled water ( %) 98 98 98 98 100 98 100 100" Alcohol (%) 2 2 2 2 0 2 0 0 The HPLC results of 50 μl fraction 1 are shown in Figure 1. The HPLC was carried out using a Waters SphersorbTM-ODS2 column with an inner diameter (ID) of 4·6 mm, a length (L) of 250 mm and a particle size of 5 μm, wherein the mobile phase was 95% H20 at 0 to 5 minutes. /5% CH3CN, 95% H20/5% CH3CN in 5 to 30 minutes, 75% H20/25% CH3CN in 30 to 80 minutes, 0% H20/100 in 80 to 100 minutes % CH3CN, gradient from 1 〇〇 to 1 〇 1 min is 〇% H20/100% CH3CN '95% H20/5% CH3CN at 1〇1 min and the flow rate is 1 ml/min. The HPLC was carried out using a Waters Alliance 2795 HT and the spectrum was taken using a Waters Photo Diode Array 2996 at a wavelength of 190 to 400 nm. As shown by the spectrum obtained at the wavelength of 200 nm, there is a sharp symmetry when the deviation coefficient is 8% and the lag time is 2.910, 5.190, 13.190 and 50.815 minutes. 〇 \83\83756 DOC -17· 1333420 The HPLC results of 50 μl of fraction 3 are shown in Figure 2. The HPLC was carried out using a Waters SphersorbTM-ODS2 column with an inner diameter (ID) of 4.6 mm, a length (L) of 250 mm and a particle size of 5 microns, wherein the mobile phase was 95% H20 for 0 to 5 minutes. /5% CH3CN, 95% H20/5% CH3CN in 5 to 3 minutes, 75% H20/25% CH3CN in 30 to 80 minutes, 〇% H20/ in 80 to 100 minutes 1〇〇% CH3CN, the gradient from 100 to 101 minutes is 〇% H2〇/i〇〇% CH3CN, 95% H20/5% CH3CN at 101 minutes, and the flow rate is 1 ml/min. The HPLC was performed using a Waters Alliance 2795 HT and the spectra were taken using a waters Photo Diode Array 2996 at a wavelength of 190 to 400 nm. As shown by the map at a wavelength of 200 nm, there is a spike at a deviation factor of 8% and hysteresis times of 2.896, 5.111, 12.944, and 46.603 minutes. Example 2: Preparation of ointment The ointment according to the present invention is as exemplified in Table 2: Table 2 Content (wt) Distillate Τ7~%~ Borneol 0.6% _ Stearic acid 5% -_Stearyl alcohol 4% __Brown Acid 4% - hexadecanol 5% Beeswax 2% Oxygen extended ethyl sorbitan monostearate 2.4% The ointment of the present invention may use any of the conventional methods commonly used in the art.

OV83\83756.DOC •18· 法製備。 實例3 .對兔全皮層傷、口之作用 對動物之治療: r重2.9至3.1公斤之新西蘭成年雌性白兔作為動物 吴土。將母二兔子單獨關在蘢中且銀以混合飼料及水。使 用25至40毫克/公斤鹽酸氯胺嗣麻醉兔子。每只兔子的背 部經徹底剪毛且割除6掄;接、人丄 且。·]除6塊面積 < 全皮層(其中每一面積為 UX1.5平方公分),其中全皮層包含表皮、真皮及肉膜。 劑量及頻率: 每只兔子之6塊面積之傷口分別使用包含分餾物i至6 之軟骨治療,每日兩次。該等軟膏以0_3 5克/平方公分之量 局部施於傷口上。 臨床傷口評價: 母日觀祭傷口且在一均勻光照、焦距及光圈條件下每周 三次使用一參考標準拍照以記錄傷口癒合過程β此外,傷 口尺寸亦經測量且如表3所示。 表3 天 使用包含下述編號之分館物之軟膏治療之傷口面積 1 2 3 4 5 6 0 100.0 100.0 100.0 100.0 1000~~~ 100 0 2 105.5 103.1 103.8 105.1 Ϊ209~~~ —117.3 ___130.0 —96.0 55.1 -204 ~~~_ 〇-5 5 108.9 110.2 105.5 100.4 ^ 1344~~~ 8 80.0 72.9 78.3 75.3 9Ϊ0 11 49.4 47.1 49.4 39.2 54Ό 14 17.9 15.1 17.0 16.5 2L0 17 7.7 6.2 9.4 9.1 Ϊ02~~~ ~74 — ~U-- 19 3.6 4.1 4.1 4.4 22 0.5 0.5 0.0 0.5 25 0.0 0.0 0.0 0.0 0?^ 結果表明傷口完全癒合(如圖3所示)。根據本發明之賦 〇 \S3\83756 DOC -19- 1333420 形劑(包含分餾物5之軟膏) 毛髮生長評價:…對治療全皮層傷口有效。 測量新毛髮之長度。使用包含分顧物丨 之所有傷口之毛髮平均長…公分(如圖二… 彼等未經治療之面積中之毛髮平均長為Gi^2:八,且 、結果表明,根據本發明之蒸氣分餘物能夠修復:二。 並刺激毛髮生長。此外,根據本發明之賦形 : 髮生長有效。 t增強毛 實例4 :對大鼠全皮層傷口之作用 對動物之治療: 自臺灣國立成功大學的實驗動物中心購得 Sprague-Dawley成年雄性大鼠。使用25至4〇毫克/公斤鹽 酸氯胺酮麻醉重300至350克之大鼠。每只大鼠的背部均 使用電動剪毛機徹底剪毛。將每只大鼠單獨關在籠中且餵 以混合飼料及水。對於每只大鼠,割除一面積為2 5 χ 2 5 平方公分之全皮層,其中該全皮層包括表皮、真皮及肉膜, 參見Β. Hafemann等人之「使用骨膠原/彈性蛋白_膜構建 真皮組織」(Use of a collagen/elastin-membrane for the tissue engineering of dermis. Burns. 1999;25:373-384 )及 H.-J. Wang等人之「使用一豬真皮模板增強廣泛擴張網眼 之薄層自體半厚皮膚之移植生長」(Use of a Porcine DermisOV83\83756.DOC •18· Method preparation. Example 3. Effect on total cortical injury and mouth of rabbits Treatment of animals: New Zealand adult female white rabbit weighing 2.9 to 3.1 kg was used as animal turmeric. The mother two rabbits were individually kept in the pot and the silver was mixed with feed and water. Rabbits were anesthetized with 25 to 40 mg/kg chloramine hydrochloride. The back of each rabbit was completely sheared and cut off 6 inches; ·] In addition to 6 areas < full cortex (each area is UX1.5 cm ^ 2), where the whole cortex contains the epidermis, dermis and meat film. Dosage and frequency: The wounds of 6 areas per rabbit were treated twice daily with cartilage containing fractions i to 6 twice daily. The ointments are applied topically to the wound in an amount of 0_3 5 g/cm 2 . Clinical Wound Evaluation: The mother-day observation wound was photographed three times a week using a reference standard under a uniform illumination, focal length, and aperture conditions to record the wound healing process. In addition, the size of the wound was also measured and is shown in Table 3. Table 3 The wound area treated with ointment containing the following number of the following items 1 2 3 4 5 6 0 100.0 100.0 100.0 100.0 1000~~~ 100 0 2 105.5 103.1 103.8 105.1 Ϊ209~~~ —117.3 ___130.0 —96.0 55.1 -204 ~~~_ 〇-5 5 108.9 110.2 105.5 100.4 ^ 1344~~~ 8 80.0 72.9 78.3 75.3 9Ϊ0 11 49.4 47.1 49.4 39.2 54Ό 14 17.9 15.1 17.0 16.5 2L0 17 7.7 6.2 9.4 9.1 Ϊ02~~~ ~74 — ~U-- 19 3.6 4.1 4.1 4.4 22 0.5 0.5 0.0 0.5 25 0.0 0.0 0.0 0.0 0?^ The results indicate complete healing of the wound (as shown in Figure 3). According to the present invention, 〇 \S3\83756 DOC -19-1333420 agent (ointment containing fraction 5) hair growth evaluation: ... is effective for treating whole cortical wounds. Measure the length of the new hair. The average length of the hair using all the wounds containing the points of the object is ... centimeters (Fig. 2... The average length of the hair in the untreated area is Gi^2: eight, and the result shows that the vapor fraction according to the present invention The remainder can be repaired: 2. It stimulates hair growth. In addition, the shape according to the invention: long-acting effect. t-enhanced hair Example 4: effect on rat whole cortical wounds Treatment of animals: from National Cheng Kung University of Taiwan Sprague-Dawley adult male rats were purchased from the Experimental Animal Center. Rats weighing 300 to 350 g were anesthetized with 25 to 4 mg/kg ketamine hydrochloride. The back of each rat was thoroughly sheared using an electric shearing machine. The rats were individually housed in cages and fed with mixed feed and water. For each rat, a full skin layer of 2 5 χ 2 5 cm 2 was cut, including the epidermis, dermis and sarcolemma, see Β. Hafemann et al., "Use of a collagen/elastin-membrane for the tissue engineering of dermis. Burns. 1999; 25: 373-384" and H.-J. Wang Waiter "Using a pig dermal template to enhance the growth of thin, self-contained, semi-thick skin of a wide-spread mesh" (Use of a Porcine Dermis)

Template to Enhance Widely Expanded Mesh Autologus Split-Thickness Skin Graft Growth. J Trauma. 1997 Feb;42(2):177-182)。Template to Enhance Widely Expanded Mesh Autologus Split-Thickness Skin Graft Growth. J Trauma. 1997 Feb;42(2):177-182).

0:'β3'83756 DOC • 20- 1333420 劑量及頻率: 使用如實例2所示之包含分館物7及8之軟膏治療兩實 驗組大鼠,且每組包含3只大鼠。該醫藥組合物以〇 35克 /平方公分之量及0.1至0.2公分之厚度局部施於傷口上。 所有傷口均用消毒紗布及彈性繃帶包紮,且每日均更換包 紮用品。 . / 所用評價方法類似於實例3中之彼等方法,且傷口尺寸 亦經測置並如表4所示。 天 _使用包占下述、.扁號之:7?猶物之軟音治療之傷口而猜(%、 7 8 '~~~ 0 100 100 —' --- 2 85.3 102.5 5 64.3 71.4 — 9 24 34.5 12 18.6 25.2 15 9.3 13.4 - 17 3.1 8.4 20 0.4 2.5 23 0.0 0.0 使用包含分餾物7及8之軟膏治療之傷口癒合。具體言0: 'β3'83756 DOC • 20-1333420 Dose and frequency: Two experimental groups of rats were treated with an ointment containing sub-packages 7 and 8 as shown in Example 2, and each group contained 3 rats. The pharmaceutical composition is applied topically to the wound in an amount of 35 g / cm 2 and a thickness of 0.1 to 0.2 cm. All wounds were wrapped with sterile gauze and elastic bandages, and the kits were replaced daily. The evaluation methods used were similar to those of Example 3, and the wound size was also measured and shown in Table 4. Day _ use the package accounted for the following, the flat number: 7? The sound of the soft sound treatment of the jealousy and guess (%, 7 8 '~~~ 0 100 100 —' --- 2 85.3 102.5 5 64.3 71.4 — 9 24 34.5 12 18.6 25.2 15 9.3 13.4 - 17 3.1 8.4 20 0.4 2.5 23 0.0 0.0 Wound healing treated with an ointment containing fractions 7 and 8.

之,使用包含分餾物7之醫藥組合物治療之傷口面積縮小 得更快。 實例5 :對皮膚深二度燒傷傷口癒合之作用 對動物之治療: · 自臺灣國互成功大學的實驗動物中心購得 .The wound area treated with the pharmaceutical composition comprising fraction 7 is reduced more rapidly. Example 5: Effect on deep wound healing of deep second-degree burns Treatment of animals: • Purchased from the Experimental Animal Center of Mutual Success University of Taiwan.

Sprague-Dawley成年雌性大鼠。使用25至4〇毫克/公斤鹽 酸氣胺酮麻醉9只重230至280克之大鼠。在每只大鼠的 背部中間之一預定傷口面積内均使用電動剪毛機徹底剪 -21 -Sprague-Dawley adult female rats. Nine rats weighing 230 to 280 g were anesthetized with 25 to 4 mg/kg of salicylamine. Use a electric shearing machine to cut completely in one of the predetermined wound areas in the middle of the back of each rat.

〇AS3'83756 DOC 1333420 毛。將每只大鼠單獨關在籠中且餵以混合飼料及水。使用 如Walker及Mason所述之方法產生大·鼠燒傷傷口,參見 Z-R. Gao等人之「將豬皮骨膠原作為傷口包紮用品用於皮 膚供體部位及皮膚深二度燒傷」(Porcine dermal collagen as a wound dressing for skin donor sites and deep partial skin thickness burns. 1992;18(6):492-496 ),其中之背部 皮膚表面透過一設計用於產生面積為4X4平方公分之皮膚 深二度燒傷之模板暴露于75°C水中1 5秒鐘。 劑量及頻率: 大鼠之實驗組(G3 )使用根據本發明之醫藥組合物治療, 其包含類似於分餾物3之分餾物9,其不同之處在於,醇之 含量係如實例2中所示之3%。大鼠之對照組(G1 )未經治 療且大鼠之比較組(G2 )經磺胺嘧啶銀藥物(由SWISS PHARMACEUTICAL CO·, LTD.生產)之治療。每組包含3 只大鼠。該藥物以0.35克/平方公分之量局部施於傷口上, 每曰兩次,直至毛髮長出為止。 臨床傷口許價'· 所用評價方法類似於實例3中之彼等方法,且傷口尺寸 經測量並如表5所示。 表5 天 G1 G2 G3 傷口面積 (平方毫米) 初始面積 之改變 (%) 傷口面積 (平方毫米) 初始面積 之改變 (%) 傷口面積 (平方毫米) 初始面積 之改變 (%) 1 1260.00 100.00 1140.67 100.00 1776.33 100.00 5 938.67 74.50 1053.33 92.34 744.00 41.88 11 285.33 22.65 428.00 37.52 154.67 8.71 14 188.00 14.92 234.67 20.57 34.67 1.95 0 V83V83756 DOC -22- -___ G ~7^---------- 天 18 傷口面積 (平方毫米) ----- 〇 〇n 初始面積 之改變 (%) VJ^ 傷口面積 (平方毫米) 初始面知 之改變 f%) G. 傷口面積 (平方毫米) 3 初始面積 之改變 (ΟΑΛ 2Γ 31 0Ό0 ' 2^〇__ 0.00 141.33 「64.67 12.39 5 67 0.00 (/〇) 0.00 〇t ___0.00 _ 0.00 0.00 41.33 32.37 ------1 —Srj U.U0 0.00 0.00 0.00 0.00 0.00 1心川裉嫁本發明之軟膏治療之傷口 ::時無症痕,且其皮膚顏色與正常皮膚顏色相同。然而, ㈣銀藥物治療之傷口上有症痕形成。另外,大 銀藥物18天時癒合’其早於彼等使用習知續胺錢 =療者(其在第37天時仍餘2·86%之傷口面積)。 係如下==數;:輪記錄。新毛髮生長之分數 紅斑;“新毛髮生長’且具有—些焦病及 Α新 "新毛髮生長’且具有-些紅斑;“〇’,指 新毛髮Λ 之傷口面積之新毛髮生長。 夹生長之分數列於表6中:〇AS3'83756 DOC 1333420 毛. Each rat was individually housed in a cage and fed with a mixed feed and water. Use a method such as that described by Walker and Mason to produce burn wounds in rats and rats. See ZR. Gao et al., "Use of pig skin collagen as a wound dressing for skin donor sites and deep second degree burns" (Porcine dermal collagen). 1992; 18(6): 492-496), wherein the surface of the back skin is designed to produce a deep second degree burn of the skin having an area of 4×4 cm 2 . The template was exposed to 75 ° C water for 15 seconds. Dosage and frequency: The experimental group (G3) of the rat was treated with the pharmaceutical composition according to the present invention, which contained a fraction 9 similar to Fraction 3, except that the alcohol content was as shown in Example 2. 3%. The rat control group (G1) was not treated and the rat comparison group (G2) was treated with silver sulfadiazine drug (produced by SWISS PHARMACEUTICAL CO., LTD.). Each group contained 3 rats. The drug was applied topically to the wound in an amount of 0.35 g/cm 2 twice a week until the hair grew. The clinical wounds were evaluated. The evaluation methods used were similar to those of Example 3, and the wound size was measured and shown in Table 5. Table 5 Day G1 G2 G3 Wound area (mm 2 ) Change in initial area (%) Wound area (mm 2 ) Change in initial area (%) Wound area (mm 2 ) Change in initial area (%) 1 1260.00 100.00 1140.67 100.00 1776.33 100.00 5 938.67 74.50 1053.33 92.34 744.00 41.88 11 285.33 22.65 428.00 37.52 154.67 8.71 14 188.00 14.92 234.67 20.57 34.67 1.95 0 V83V83756 DOC -22- -___ G ~7^---------- Day 18 Wound area ( Square mm) ----- 〇〇n Change in initial area (%) VJ^ Wound area (mm 2 ) Initial change in knowledge f%) G. Wound area (mm 2 ) 3 Change in initial area (ΟΑΛ 2Γ 31 0Ό0 ' 2^〇__ 0.00 141.33 "64.67 12.39 5 67 0.00 (/〇) 0.00 〇t ___0.00 _ 0.00 0.00 41.33 32.37 ------1 —Srj U.U0 0.00 0.00 0.00 0.00 0.00 The wound treated by the ointment of the present invention is: no symptoms, and the skin color is the same as the normal skin color. However, (4) the silver drug treatment has a symptom on the wound. In addition, the large silver drug heals at 18 days' It is earlier than them Use the conventional amines = therapist (which still has 2.86% of the wound area on the 37th day). The following == number;: round record. New hair growth fraction erythema; "new hair growth" and has - Some of the scorch and new "new hair growth' have some erythema; "〇" refers to the new hair growth of the wound area of the new hair. The scores of the clip growth are listed in Table 6:

〇:伽3756 〇〇C -23- 1333420 之新毛髮生長。在使用根據本發明之醫藥組合物治療之傷 口中未發現紅斑及焦痂。然而,當使用習知藥物治療時未 觀察到新毛髮生長。 皮膚之組織學評價: 傷口徹底癒合後,取每只大鼠之皮膚組織且對其麻醉以 使用如B · Hafemann等人所述之評價方法實施組織學檢 查’參見B. Hafemann等人之「使用骨膠原/彈性蛋白_膜 構建真皮組織」(Use of a collagen/elastin-membrane f〇r the tissue engineering of dermis. Burns. 1999;25:373-384 )。取 出樣品且將其存儲在甲醛中。將每一樣品包埋於一石壤封 閉中且製備薄切片,並使用蘇木精-伊紅法染色。在—光學 顯微鏡及一穿透式電子顯微鏡下觀察樣品。 組織學檢查結果表明,未經治療之大氧上皮組織(如圖 5所示)之厚度不均勾’且顆粒層變厚。纖維層可在深皮層 中觀察到。使用習知項胺π密咬銀藥物治療之大鼠組(如圖6 所示)中亦表明具有厚度不均勻之上皮組織。纖維層可在 深皮層中觀察到,且毛囊受到破壞。另一方面,使用根據 本發明之軟膏治療之傷口(如圖7所示)看來是正常的, 且大量毛囊再生。纖維層可在皮膚表面區域觀察到。 實例6 :對大鼠中大面積全皮層傷口之作用 對動物之治療: 自臺灣國立成功大學的實驗動物中心講得 Sprague-Dawley成年雄性大鼠。使用25至40毫克/公斤鹽 酸氣胺酮麻醉重300至350克之大鼠。每只大鼠的背部均 O:\83\83756 D0C -24· 1333420 使用電動剪毛機徹底剪毛。將每只大鼠單獨關在籠中且餵 以混合飼料及水。對於每只大鼠,割除一面積為4.0 X 4.0 平方公分之全皮層,其中該全皮層包含表皮、真皮及肉膜。 劑量及頻率: 大鼠之實驗組使用包含如實例5中所示之分餾物9之軟 膏治療。本發明亦提供一使用磺胺嘧啶銀藥物(由SWISS PHARMACEUTICAL CO.,LTD.生產)治療之大鼠之比較組 (G2)。每組含5只大鼠。該軟膏以0.75克/平方公分之量 且0.1至0.2公分之厚度局部施於傷口上。所有傷口均用消 毒紗布及彈性繃帶包紮,且每日均更換包紮用品。 所用評價方法類似於實例3中所用之彼等方法,且傷口 尺寸亦經測量並如表7所示。 表7 項胺α密咬銀藥物 包含分餾物3之軟膏 天 傷口面積 初始面積之改變 傷口面積 初始面積之改變 (平方毫米) (%) (平方毫米) (%) 1 1977.60 100.00 1957.60 100.00 3 1763.20 89.16 1784.80 91.17 5 1444.80 73.06 1506.40 76.95 7 990.40 50.08 1265.60 64.65 9 556.00 28.11 768.80 39.27 11 429.60 21.72 456.80 23.33 13 368.80 18.65 385.60 19.70 15 283.20 14.32 299.20 15.28 17 208.80 10.56 236.80 12.10 19 166.00 8.39 238.40 12.18 21 131.00 6.62 161.60 8.26 23 119.00 6.02 123.20 6.29 25 87.00 4.40 88.00 4.50 27 45.00 2.28 76.00 3.88 29 40.00 2.02 56.00 2.86 31 35.00 1.77 34.40 1.76 35 18.00 0.91 20.00 1.02 33 16.00 0.81 8.00 0.41 37 0.00 0.00 0.00 0.00 〇 \83\83756 DOC -25 · 在傷口癒合進程中,使用根據本發明之軟膏治療之傷口 可’α癒且揲過敏反應。然而,使用磺胺嘧啶銀藥物治療之 傷口上可形成疤痕。另外,在使用磺胺嘧啶銀藥物治療之 傷口中可觀察到嚴重的過敏反應。使用根據本發明之醫藥 組合物治療之大鼠之復原速度(約25至31天)快於彼等 使用磺胺嘧啶銀藥物治療者(約37天)。 皮膚之組織學評價: 用於組織學評價之方法係如實例5中所述。 在第45天實施之組織學檢查結果表明,可在使用習知磺 胺嘧哫銀藥物治療之傷口深皮層内觀察到纖維層。某些上 皮細胞死ΤΓ且形成癒痂。在皮膚中可觀察到慢性炎症及嗜 伊、’’X ,’’田胞滲透—者。某些纖維亦可形成於距離傷口 〇 5公 分處。 在使用根據本發明之軟膏治療之大鼠之組中,新生上皮 係平整的,且大量毛囊產生。僅形成少量纖維。 在第95天貫施之組織學檢查結果表明,可在使用習知磺 胺喊呢銀藥物治療之傷口上觀察到不均勻上皮層(如圖8 所示)。纖維層形成於深皮層中。少量毛囊產生。 在使用根據本發明之軟膏治療之大鼠之組中,新生上皮 係平整的,且大量毛囊產生(如圖9所示)。 實例7 :對局部電子輻射皮膚損傷之作用 對動物之治療·· 自臺灣國立成功大學的實驗動物中心購得 ptague-Dawley成年雌性大鼠。將重25〇至3〇〇克之大鼠〇: New hair growth of gamma 3756 〇〇C -23- 1333420. No erythema or eschar was found in the wound treated with the pharmaceutical composition according to the present invention. However, no new hair growth was observed when treated with conventional drugs. Histological evaluation of the skin: After the wound was completely healed, the skin tissue of each rat was taken and anesthetized to perform histological examination using an evaluation method as described by B. Hafemann et al. 'See B. Hafemann et al. Use of a collagen/elastin-membrane f〇r the tissue engineering of dermis. Burns. 1999; 25: 373-384). The sample was taken and stored in formaldehyde. Each sample was embedded in a stone soil closure and thin sections were prepared and stained using the hematoxylin-eosin method. The samples were observed under an optical microscope and a transmission electron microscope. The results of histological examination showed that the untreated large oxygen epithelial tissue (as shown in Fig. 5) was uneven in thickness and the granular layer became thick. The fibrous layer can be observed in the deep cortex. The uneven skin epithelial tissue was also shown in the rat group (shown in Figure 6) treated with a conventional amine π-bite silver drug. The fibrous layer can be observed in the deep cortex and the hair follicles are destroyed. On the other hand, the wound treated with the ointment according to the present invention (as shown in Fig. 7) appears to be normal, and a large amount of hair follicles are regenerated. The fibrous layer can be observed in the surface area of the skin. Example 6: Effect on large-area whole cortical wounds in rats Treatment of animals: Sprague-Dawley adult male rats were spoken from the Experimental Animal Center of National Cheng Kung University in Taiwan. Rats weighing 300 to 350 grams were anesthetized with 25 to 40 mg/kg of amiodarone. The back of each rat was O:\83\83756 D0C -24· 1333420 Thoroughly cut with an electric shearing machine. Each rat was individually housed in a cage and fed with mixed feed and water. For each rat, a full skin layer of 4.0 X 4.0 cm2 was cut, wherein the whole skin layer contained the epidermis, dermis, and meat membrane. Dosage and frequency: The experimental group of rats was treated with a soft paste containing fractionated product 9 as shown in Example 5. The present invention also provides a comparative group (G2) of a rat treated with a silver sulfadiazine drug (produced by SWISS PHARMACEUTICAL CO., LTD.). Each group contained 5 rats. The ointment was applied topically to the wound in an amount of 0.75 g/cm 2 and a thickness of 0.1 to 0.2 cm. All wounds were wrapped with sterile gauze and elastic bandages and the dressing was changed daily. The evaluation methods used were similar to those used in Example 3, and the wound size was also measured and shown in Table 7. Table 7 Change of initial area of wound area of ointment α-bite silver drug containing fraction 3; change of initial area of wound area (mm 2 ) (%) (mm 2 ) (%) 1 1977.60 100.00 1957.60 100.00 3 1763.20 89.16 1784.80 91.17 5 1444.80 73.06 1506.40 76.95 7 990.40 50.08 1265.60 64.65 9 556.00 28.11 768.80 39.27 11 429.60 21.72 456.80 23.33 13 368.80 18.65 385.60 19.70 15 283.20 14.32 299.20 15.28 17 208.80 10.56 236.80 12.10 19 166.00 8.39 238.40 12.18 21 131.00 6.62 161.60 8.26 23 119.00 6.02 123.20 6.29 25 87.00 4.40 88.00 4.50 27 45.00 2.28 76.00 3.88 29 40.00 2.02 56.00 2.86 31 35.00 1.77 34.40 1.76 35 18.00 0.91 20.00 1.02 33 16.00 0.81 8.00 0.41 37 0.00 0.00 0.00 0.00 〇\83\83756 DOC -25 · In the process of wound healing Among them, the wound treated with the ointment according to the present invention can be an allergic reaction. However, scars can be formed on wounds treated with silver sulfadiazine. In addition, severe allergic reactions were observed in wounds treated with silver sulfadiazine. The recovery rate (about 25 to 31 days) of the rats treated with the pharmaceutical composition according to the present invention was faster than those treated with the silver sulfadiazine drug (about 37 days). Histological Evaluation of Skin: The method used for histological evaluation was as described in Example 5. The histological examination performed on the 45th day showed that the fibrous layer could be observed in the deep cortex of the wound treated with the conventional sulfadiazine silver drug. Some epithelial cells die and form more. Chronic inflammation and opiate, ''X,'' field penetration can be observed in the skin. Some fibers can also be formed 5 cm from the wound. In the group of rats treated with the ointment according to the present invention, the neonatal epithelium was flat and a large number of hair follicles were produced. Only a small amount of fiber is formed. Histological examinations performed on day 95 indicated that an uneven epithelial layer (as shown in Figure 8) was observed on wounds treated with conventional sulfonamides. The fibrous layer is formed in the deep cortex. A small amount of hair follicles are produced. In the group of rats treated with the ointment according to the present invention, the neonatal epithelium was flat and a large number of hair follicles were produced (as shown in Fig. 9). Example 7: Effect on local electron radiation skin damage Treatment of animals · ptague-Dawley adult female rats were purchased from the Experimental Animal Center of National Cheng Kung University, Taiwan. Rats weighing 25 to 3 grams

〇 \83\83756 D〇C •26- 1333420 單獨關在籠中且餵以混合飼料及水。 大鼠藉由使用類似於如John E. Moulder及James J. Fischer所述之方法實施輕射,參見「大鼠皮膚之輕射反應: 分餾物之數量之作用及總治療時間」(RADIATION REACTION OF RAT SKIN: The role of the Number of〇 \83\83756 D〇C •26- 1333420 Separately in cages and fed with mixed feed and water. Rats were subjected to light shots using methods similar to those described by John E. Moulder and James J. Fischer, see "Light-Effect Reaction of Rat Skin: Effect of Number of Fractions and Total Treatment Time" (RADIATION REACTION OF) RAT SKIN: The role of the Number of

Fractions and the Overall Treatment Time. Cancer June 1976;37(6):2762-2767 )。輻射前在大鼠腹膜内使用40至50 毫克/公斤戊巴比妥鈉鹽(TCI.TOKYO )來麻醉大鼠。完全 切去臀肌區域上之皮膚,且於輻射前在預期之2X2平方公 分之輻射面積之右側及左侧臀肌上作標記。施加藉由一線 性加速器(Varian Associates,Inc.,CA, U.S.A.制)產生之 6MeV能量之電子束實施照射。 測試分次及單次劑量照射《在分次照射中,3只大鼠之 右側及左侧臀肌區域受到照射。該照射每周實施兩次,實 施五周,且每一區域上之總劑量係37.5Gy。Fractions and the Overall Treatment Time. Cancer June 1976; 37(6): 2762-2767). Rats were anesthetized with 40 to 50 mg/kg pentobarbital sodium salt (TCI. TOKYO) in the rat peritoneum before irradiation. The skin on the gluteal region is completely cut and marked on the right side of the expected 2X2 square centimeter of radiation area and on the left gluteal muscle before irradiation. Irradiation was carried out by applying an electron beam of 6 MeV energy generated by a linear accelerator (manufactured by Varian Associates, Inc., CA, U.S.A.). Test fractionation and single dose irradiation "In fractional irradiation, the right and left gluteal muscle regions of 3 rats were irradiated. The irradiation was performed twice a week for five weeks and the total dose on each area was 37.5 Gy.

劑量及頻率:Dosage and frequency:

在分次照射中以0.25克/平方公分之劑量每日照射一次 後之輻射傷使用包含如實例5中所示之分餾物9 ( G1 )之 軟膏治療,且單次劑量照射中之輻射傷每日實施兩次治 療。未經治療之大鼠用作對照(G2 )。未接受照射之大鼠之 空白組(G3 )作為空白。 臨床評價‘· 評價並記錄照射後30天之皮膚反應分數,參見Yoshinao Abe及Muneyasu Urano之「經多次每日兩次劑量之照射後 Ο \83\83756 DOC -27- 1333420 小鼠的部分側依賴性急性皮膚反應」(Fraction side-dependent Acute Skin Reaction of Mice after Multiple Twice-A-Day Doses. Int. J. Radiation Oncology Biol. Phys. 1990 Feb; 18(2):359-364)及 Yu-Jen Chen 等人之「粉防己域 及雷公根萃取物對大鼠中急性輻射皮炎之作用」(The Effect of Tetrandrine and Extracts of Centella asiatica on Acute Radiation Dermatitis in Rats. Biol. Pharm. Bull. 1999 July;22(7):703-706 )。皮膚反應分數係如下定義:“〇,’指 正常皮膚;“ 〇 · 5 ”指少於5 0 %之經照射區域出現輕微脫 毛’或毛髮變色;“1.0”指約50%之照射區域出現脫毛; “1.5”指超過50%之照射區域出現脫毛且某些脫毛伴隨 皮膚發紅;“2·0”指少於50%之照射區域出現完全脫毛及 乾脫皮;“2.5”指超過50%之照射區域出現乾脫皮; “3.〇”指出現某些濕脫皮;“3.5”指大部分區域出現濕脫 皮。 該皮膚反應分數經評價且如表8所示The radiation injury after daily irradiation at a dose of 0.25 g/cm 2 in fractional irradiation was treated with an ointment containing fractionation 9 (G1) as shown in Example 5, and the radiation injury per single dose irradiation was Two treatments were performed on the day. Untreated rats were used as controls (G2). A blank group (G3) of the rats that did not receive the irradiation was used as a blank. Clinical evaluation'· Evaluate and record the skin reaction scores 30 days after irradiation, see Yoshinao Abe and Muneyasu Urano “After multiple daily doses of Ο 83 \83\83756 DOC -27-1333520 part of the mouse Fraction side-dependent Acute Skin Reaction of Mice after Multiple Twice-A-Day Doses. Int. J. Radiation Oncology Biol. Phys. 1990 Feb; 18(2): 359-364) and Yu- Jen Chen et al., "The Effect of Tetrandrine and Extracts of Centella asiatica on Acute Radiation Dermatitis in Rats. Biol. Pharm. Bull. 1999 July; 22(7): 703-706). The skin reaction score is defined as follows: “〇, 'refers to normal skin; “〇· 5 ” means that less than 50% of the irradiated areas have slight hair loss' or hair discoloration; “1.0” means that about 50% of the irradiated areas are depilated. "1.5" means that more than 50% of the irradiated areas are depilated and some of the depilation is accompanied by redness of the skin; "2.0" means that less than 50% of the irradiated areas are completely depilated and dry peeled; "2.5" means more than 50% Dry peeling occurred in the irradiated area; “3.〇” means some wet peeling; “3.5” means wet peeling in most areas. The skin reaction score was evaluated and as shown in Table 8.

O:\83\83756.DOC -28- 1333420 膚未顯示過敏反應。 該結果類似於彼等分次照射測試中者。 皮膚之組織學評價: 所用評價方法類似於實例5中所用之彼等方法。 在G1中(如圖1〇所示)發現表皮細胞覆蓋於多層上皮 細胞上。大量毛囊亦再生。 在G2中(如圖11所示),僅觀察到少量毛囊。 在G3中(如圖12所示),該組織作為對照。 經治療之傷口組織較緻密,但彼等未經治療者較鬆弛。 實例8 :對兔耳皮膚炎之作用 & 如圖13所示,頃發現兔耳皮膚炎具有充血、腫脹、炎症、 潰癌及出血之症狀。 對傷口施用3天根據本發明之軟膏,其包含類似於分铜 物3之分餾物10’不同之處在於,其中之醇含量係如實例 2中所示之〇%。 在第1天,潰瘍消失且充血減輕。毛囊出現’如圖14所 示。 在第2天,皮膚組織恢復且僅觀察到輕微發紅。毛囊明 顯可見,如圖15所示。 在第3天,皮膚組織及顏色正常。毛髮在毛囊上生長, 如圖16所示。 實例9 :對糖尿病創傷之作用 68歲男性患糖尿病20年。其左腳腳趾已切除。傷口 顯示嚴重的壞疽變化,如圖17所示。其右腳的全部腳趾已O:\83\83756.DOC -28- 1333420 Skin did not show an allergic reaction. This result is similar to those in the fractional exposure test. Histological evaluation of skin: The evaluation methods used were similar to those used in Example 5. In G1 (as shown in Figure 1A), epidermal cells were found to coat multiple layers of epithelial cells. A large number of hair follicles are also regenerated. In G2 (as shown in Figure 11), only a small number of hair follicles were observed. In G3 (as shown in Figure 12), the tissue served as a control. The treated wound tissue is denser, but they are more slack without treatment. Example 8: Effect on dermatitis of rabbit ears & As shown in Fig. 13, it was found that dermatitis of rabbit ears has symptoms of congestion, swelling, inflammation, ulceration and bleeding. The ointment according to the present invention was applied to the wound for 3 days, and it contained a fraction 10' similar to the copper fraction 3, except that the alcohol content was as % as shown in Example 2. On the first day, the ulcer disappeared and the congestion was reduced. Hair follicles appear as shown in Figure 14. On day 2, skin tissue recovered and only a slight redness was observed. The hair follicles are clearly visible, as shown in Figure 15. On the third day, the skin tissue and color were normal. Hair grows on the hair follicles, as shown in Figure 16. Example 9: Effect on Diabetes Trauma A 68-year-old man has diabetes for 20 years. Its left toe has been removed. The wound showed severe gangrene changes, as shown in Figure 17. All the toes of its right foot have

O:\83\83756.DOC -29· 1333420 如圖18所示。 施於傷口,每曰 如圖19所示), 而無更多壞死。 2至3次。 可注意到某些肉 被切除但傷口癒合不佳, 將包含分餾物9之軟膏 左腳經2個月治療後( 芽組織,且傷口開始癒合 左腳經5個月治r α _ _ . 口療後(如圖20所示),傷口完全癒合且 不留症痕。右腳(如圖2丨所 … 口“所不)亦一全癒合且不留疤痕。 實例10 :對慢性瘀積性溃瘍之作用 如圖22所示,一 80盡里u·、 歲男性又兩側下肢患色素沈著過度 及齋積性潰療20年。 將包含分餾物9之軟膏施於傷口上,每日2至3次。 腳部t 2周治療後(如圖23所示),傷口開始癒合。 腳部,.工4周/σ療後(如圖24所示),傷口完全療合且不 留泡痕。 實例11 :對齋斑之作用 女性患者患有車禍造成之瘀斑(如圖25所示)。 每日使用一久冷敷布對該傷口預先治療三天,且隨後每 日2至3次施用包含分餾物9之軟膏。 如圖2 6所示,瘀斑消失且傷口在治療後第三天癒合。車 禍刖已存在 < 疤痕及顏色在治療7天後亦變平及變淺(如 圖27所示)。 實例12 :對擦傷之作用 如圖28所示,-女性患者患有車禍引起之皮膚擦傷。 將包含分餾物9之軟膏施於傷口上,每日2至3次。 傷口在治療7天後癒合(如圖29所示)。 O:\83\83756 DOC -30· 1333420 實例13 :對缝合傷口之作用 一男性患者患有嚴重撕裂傷口,it人中上且女 ’、 ”哥3公分裂 口及20針縫線、鼻梁上具有〇 8公分裂口 H計缝線且上 唇上各具有1公分裂口及6針缝線與丨.5公分到 A刀製口及8針 縫線。 將包含分餾物9之軟膏施於傷口上,每日2至 傷口完全癒合且不留疤痕(如圖3〇所示)。 實例14 :對特應性皮炎之作用 一 4.5歲女童患慢性特應性皮炎。如圖31戶斤示,經長期 局部皮質類固醇治療後,其頸部及上胸之皮膚發癢、充血、 腫脹、裂開、滲出、結痂並有鱗屑。 至3次。 、腫脹、裂 將包含分餾物ίο之軟膏施於傷口上,每日2 經1周治療後(如圖32所示),發疼、充血 開、滲出、結痂及鱗屑減少及減弱。 皮膚損傷幾乎消退。 皮膚損傷完全癒合且隨 經4周治療後(如圖3 3所示), 經6周治療後(如圖34所示), 後無回彈作用。 儘管已闡釋及描述本發明之具體實施例 I 二 _ .热Tf此項 藝者仍可實施各種修飾及改良。从 L. g . 7久(又艮。故,本發明又具體實施 僅用於闡釋之目的而非料太议^ 7向非對本發明加以限足。本發明並不O:\83\83756.DOC -29· 1333420 is shown in Figure 18. Apply to the wound, as shown in Figure 19, without more necrosis. 2 to 3 times. It can be noticed that some meat is removed but the wound is not healed. The ointment containing the fraction 9 will be treated for 2 months (the bud tissue, and the wound begins to heal the left foot for 5 months. r α _ _ . After treatment (as shown in Figure 20), the wound healed completely without leaving a scar. The right foot (as shown in Figure 2) was completely healed without scarring. Example 10: Chronic hoarding The role of the ulcer is shown in Figure 22. One in eight men, the old man and the lower extremities suffer from hyperpigmentation and satiety therapy for 20 years. Apply the ointment containing fraction 9 to the wound, daily 2 Up to 3 times. After 2 weeks of treatment of the foot t (as shown in Figure 23), the wound begins to heal. Foot, work 4 weeks / after σ treatment (as shown in Figure 24), the wound is completely cured and does not leave bubbles Example 11: Effect on Ramadan Female patients have ecchymosis caused by a car accident (as shown in Figure 25). The wound is pre-treated for three days with a long cold compress, and then administered 2 to 3 times a day. The ointment containing the fraction 9. As shown in Fig. 26, the ecchymosis disappears and the wound heals on the third day after the treatment. The car accident 刖 already exists < The marks and colors also flattened and became lighter after 7 days of treatment (as shown in Figure 27). Example 12: Effect on abrasions As shown in Figure 28, - female patients suffered from skin abrasions caused by car accidents. The ointment of 9 is applied to the wound 2 to 3 times a day. The wound heals after 7 days of treatment (as shown in Figure 29). O:\83\83756 DOC -30· 1333420 Example 13: Effect on suture wounds Male patients with severe tear wounds, it is in the middle of the female and female, "Gang 3 Gong split mouth and 20 stitches suture, the nose bridge has a 公 8 male split mouth H count suture and the upper lip has 1 split and 6 needles The suture and 丨5 cm to the A knife mouth and the 8 needle suture. Apply the ointment containing the fraction 9 to the wound, 2 days until the wound is completely healed without leaving scars (as shown in Figure 3). Example 14: Effect on atopic dermatitis A 4.5-year-old girl suffers from chronic atopic dermatitis. As shown in Figure 31, after long-term topical corticosteroid treatment, the skin of the neck and upper chest is itchy, congested, and swollen. , splitting, oozing, crusting and scaly. Up to 3 times., swelling, cracking will contain fractions ίο soft The cream is applied to the wound, after 2 weeks of treatment per day (as shown in Figure 32), pain, congestion, exudation, scarring and scaling are reduced and weakened. Skin damage almost subsides. Skin damage completely heals and follows After 4 weeks of treatment (as shown in Fig. 3), after 6 weeks of treatment (as shown in Fig. 34), there is no rebound effect. Although the specific embodiment I of the present invention has been explained and described, the heat Tf is The artist can still implement various modifications and improvements. From L. g. 7 for a long time (and therefore, the present invention has been embodied for the purpose of illustration only, and is not intended to limit the invention. The invention is not

於所闡述之特定形式,T,杳& A Λ 且不違音本發明之主旨及範圍之 有修飾均在隨附申請糞南丨益阁. 4 Τ叫寻利範圍所定義之範圍内。 .圖式簡單說明]In the specific form set forth, T, 杳 & A 且 and without contradicting the subject matter and scope of the present invention are modified within the scope defined by the accompanying application. .Simple description of the schema]

圖1不出了藉由根據本發明之方法獲得之分館物! 〇^83\83756 〇〇C -31 - 1333420 lb . 20至4〇分鐘; 明之軟膏治療全皮層 HPLC圖譜;圖la ·· 0至20分鐘;圖 圖1 c · 4 0至6 0分鐘。 方法獲得之分餾物3之 圖2b : 20至4〇分鐘; 圖2示出了藉由根據本發明之 HPLC圖譜;圖2a : 0至20分鐘; 圖2c ·· 40至60分鐘。 圖3示出了實例3中使用根據本發 傷口之照片。 療之全皮 至3之軟 圖4不出了實例3中使用根據本發明之軟膏治 :傷口上之毛髮生長照片;W 4a:包含分餘物: 霄,圖4b:包含分館物4至6之軟膏。 圖5示出了實例5中未經治 學檢查結果。 療之深二度燒傷傷 口之組織 藥物治療之深二度燒 明之軟膏治療深二度 藥物治療之大面積全 圖6示出了實例5中經磺胺嘧啶銀 傷傷口之組織學檢查結果。 圖7示出了實例5中使用根據本發 燒傷傷口之組織學檢查結果。 圖8示出了實例6中經磺胺嘧啶銀 皮層傷口之組織學檢查結果。 膏治療大面積 圖9示出了實例6中使用根據本發明之軟 全皮層傷口之組織學檢查結果。 圖丨〇示出了實例7中使用根據本發明之 膚損傷之組織學檢查結果。 β〜療輕射皮 圖U示出了實例7中未經治療之轉射 檢查結果。 又;胃知傷之組織學Figure 1 shows the sub-brows obtained by the method according to the invention! 〇^83\83756 〇〇C -31 - 1333420 lb. 20 to 4 minutes; Mingzhi ointment treatment of whole cortex HPLC map; Fig. la ·· 0 to 20 minutes; Fig. 1 c · 40 to 60 minutes. Figure 2b: 20 to 4 minutes; Figure 2 shows the HPLC spectrum according to the invention; Figure 2a: 0 to 20 minutes; Figure 2c - 40 to 60 minutes. Fig. 3 shows a photograph of the wound according to the present invention used in Example 3. The treatment of the whole skin to 3 soft Figure 4 is not used in Example 3 using the ointment according to the invention: hair growth photos on the wound; W 4a: containing the remnant: 霄, Figure 4b: containing the sub-district 4 to 6 Ointment. Fig. 5 shows the results of the non-learning test in Example 5. The treatment of the deep second degree burn wound tissue The deep second degree of drug treatment The clear ointment treatment of deep second degree The large area of drug treatment Figure 6 shows the histological examination results of the sulfadiazine silver wound in Example 5. Fig. 7 shows the results of histological examination using the burn wound according to the present invention in Example 5. Figure 8 shows the results of histological examination of the sulfadiazine silver skin wound in Example 6. Cream Treatment Large Area Figure 9 shows the results of histological examination of the soft whole cortical wound according to the present invention in Example 6. The figure shows the results of histological examination using the skin lesion according to the present invention in Example 7. 〜~therapy light shot Figure U shows the results of the untreated transfer test in Example 7. And the histology of stomach injury

O:\83\83756.DOC -32- 1333420 圖12示出了實例7中正常組織之結果。 ΙΓ示出τ實例8中兔耳皮膚炎治療前之昭片 .4不出了實例8中使用根據本發 、片 膚炎後第1天之照片。 又敕膏治療免耳座 圖15示出了實例8中使用根據本發 膚炎後第2天之照片。 又敕霄治療兔耳片 圖16 ~ 6不出了實例8中使用根據本發 膚夫後第3天之照片。 a &lt;軟貧治療兔耳座 圖17 - ^出了實例9中糖尿病創傷 圖1 S - 〜’,H片。 出了實例9中糖尿病創 圖1 Q + , …、芍。 不出了實例9中使用根據本發 創傷2個月後之照片。 Λ艾敕貧治療糖尿病 圖20示出了實例9中使用根據本發明、 創Θ 5個月後之照片。 人膏〉台療糖尿病 圖以示出了實例9中使用根據本發春 創傷5個月後之照片。 人θ冶療糖尿病 圖22示出了實例1()中慢性齋積性溃療之防 圖23示出了實例10中使用根據本發明、:片/ 瘀積性潰瘍2周後之照片。 〈軟骨治療慢性 圖24示出了實例1〇中使用根據本發 齋積性潰癌· 4周後之照片。 人骨治療慢性 圖25示出了實例11中瘀斑之照片。 圖26示出了實例丨丨中使用根據本發明、 天後之照片。 人膏治療齋斑3O: \83\83756.DOC -32 - 1333420 Figure 12 shows the results of normal tissue in Example 7. ΙΓ shows the smear of the rabbit ear dermatitis before the treatment of τ in Example 8. 4 The photograph of the first day after the dermatitis according to the present invention was used in Example 8. Further ointment treatment ear-free seat Fig. 15 shows a photograph of the second day after the use of the skin inflammation in Example 8. Further treatment of rabbit ears Fig. 16 to 6 shows the photograph of the third day after the use of the hair follicle in Example 8. a &lt;soft poor treatment of rabbit ear seat Figure 17 - ^ Example 9 diabetes wound Figure 1 S - ~ ', H piece. In the case of the diabetes in Example 9, Q + , ..., 芍. A photograph of the use of the wound according to the present invention for 2 months after the use of the present invention is not shown. Λ 敕 治疗 治疗 治疗 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图 图The human ointment was used to treat diabetes. The figure shows the photograph of the use of the spring wound according to the present invention for 5 months. Human θ treatment of diabetes Fig. 22 shows the prevention of chronic sagittal ulceration in Example 1 (). Fig. 23 shows a photograph of the use of the tablet/creulous ulcer according to the present invention in Example 10 after 2 weeks. <Cholesterol treatment chronic Fig. 24 shows a photograph of the use of the cancer in accordance with the present invention in Example 1 for 4 weeks. Human Bone Treatment Chront Figure 25 shows a photograph of Freckle in Example 11. Fig. 26 shows a photograph of the use of the day according to the present invention in the example. Human cream treatment of Ramadan 3

O:\83\83756 DOC -33- 1333420 圖27示出了實例11中使用根據本發明之軟膏治療瘀斑7 天後之照片。 圖28示出了實例1 2中擦傷之照片。 圖29示出了實例1 2中使用根據本發明之軟膏治療瘀斑 7天後之照片。 圖30示出了實例13中使用根據本發明之軟膏治療缝合 傷口之照片。 圖3 1示出了實例14中特應性皮炎之照片。 圖32示出了實例14中使用根據本發明之軟膏治療特應 性皮炎1周後之照片。 圖33示出了實例14中使用根據本發明之軟膏治療特應 性皮炎4周後之照片。 圖34示出了實例14中使用根據本發明之軟膏治療特應 性皮炎6周後之照片。 O:\83\83756 DOC -34-O: \83\83756 DOC -33 - 1333420 Figure 27 shows a photograph of the treatment of ecchymosis using the ointment according to the present invention in Example 11 for 7 days. Figure 28 shows a photograph of the scratch in Example 12. Figure 29 shows a photograph of the treatment of ecchymosis 7 days after the use of the ointment according to the present invention in Example 12. Figure 30 is a photograph showing the treatment of a suture wound using the ointment according to the present invention in Example 13. Figure 31 shows a photograph of atopic dermatitis in Example 14. Fig. 32 is a photograph showing the treatment of atopic dermatitis 1 week after the use of the ointment according to the present invention in Example 14. Fig. 33 is a photograph showing the treatment of atopic dermatitis 4 weeks after the use of the ointment according to the present invention in Example 14. Figure 34 is a photograph showing the treatment of atopic dermatitis in Example 14 using the ointment according to the present invention for 6 weeks. O:\83\83756 DOC -34-

Claims (1)

1333420 」」」 第092122224號專利申請案 中文申請專利範圍替換本(94年5月) 拾、申請專利範園: 1. 一種自大豆(G/_ychema;c(L.)Merr.)種子獲得之蒸氣分 餾物,該蒸氣分餾物係由包含下述步驟之方法製備: (a) 棱供該種子在一醇溶液(其含有濃度低於約15%wt之 醇)或水中之粗萃物;及 (b) 在大氣壓力低於約1 atm且溫度低於約110°C下蒸發 該粗萃物以獲得該蒸氣分餾物; 其中使用内徑(I.D.)為4.6毫米、長度(L)為250毫米 且顆粒大小為5微米之Waters SphersorbTM-ODS2管柱藉 由高效液相層析(HPLC )于200奈米波長取得之50微 升蒸氣分餾物之圖譜包括偏離係數為8%且遲滯時間為 2.910、5.190、13.190及50.815分鐘之峰值,其中流動 相在0至5分鐘為95% H20/5% CH3CN,在5至30分鐘 之梯度為95% H20/5% CH3CN,在30至80分鐘之梯度為 75% H20/25°/〇 CH3CN,在 80 至 100 分鐘之梯度為 0% H20/100% CH3CN,在 100至 101分鐘之梯度為 0% H20/100°/〇 CH3CN,在 101 分鐘為 95% H20/5% CH3CNf,. 且流速為1毫升/分鐘。 2. 如申請專利範圍第1項之蒸氣分餾物,其中該蒸氣分餾 物藉由冷卻蒸氣以液體形式收集。 3. 如申請專利範圍第1項之蒸氣分餾物,其中該醇之濃度 低於約5 % wt。 4. 如申請專利範圍第1項之蒸氣分餾物,其中步驟(a)中 之粗萃物係在水中。 83756-940530.doc 1333420 5·如申請專利範圍第1項之蒸氣分餾物,其中步驟(b)中 之溫度介於約60°C至約110°C之間。 6. 如申請專利範圍帛1 g之蒸氣分餘⑯,其具有治療皮膚 損傷、治療皮膚病、刺激細胞再生及刺激毛髮生長之 用。 炙乍 7. 一種包含如申請專利範園第丨項之蒸氣分餾物之組合物。 戈申專利|巳圍第7項之組合物,其用於製造醫藥組人 物、化妝品組合物或皮膚清潔組合物。 9.如申請專利範圍第7項之組合物,其用於治療皮膚損傷 或皮膚病。 10·如申請專利範圍第9項之組合物,其中該皮膚損傷或皮 膚病係選自由燒傷、曬傷 '輻射傷、急性及慢性損傷、 瘀斑、皮炎、斑點、丘疹、小結、水皰、大水皰、膿皰、 風疹塊、斑塊、囊腫、鱗屑病、痂、裂隙、潰瘍 '粉刺、 皮膚乾燥症、脫皮、瘙癢、變應性濕疹、疹、壞疽 '慢 性瘵積性丨貴瘍、擦傷、特應性皮炎、缝合傷口、糖尿病 創傷及毛囊缺損組成之群。 11. 如申请專利範圍第9項之組合物,其中該皮膚損傷或皮 膚病係選自由燒傷、輻射傷、急性及慢性損傷、皮炎、 壞疽、慢性瘀積性潰瘍、擦傷、特應性皮炎、縫合傷口、 糖尿病創傷及毛囊缺損組成之群。 12. 如申請專利範圍第7項之組合物,其進一步包含一抗菌 劑。 3 ’如申叫專利輯圍第7項之組合物,其進一步包含冰片、 83756-940530.doc 1333420 硬脂酸、硬脂醇、棕櫚酸、十六烷醇、蜂蠟及聚氧伸乙 基去水山梨醇單硬脂酸酯。 14. 一種用於治療患者皮膚損傷或皮膚病之醫藥組合物,其 包含可有效治療皮膚損傷、治療皮膚病、刺激細胞再生 及刺激毛髮生長之足夠量之如申請專利範圍第7項之組 合物。 83756-940530.doc1333420 》" Patent Application No. 092122224 Replacement of Chinese Patent Application (May 1994) Pick up and apply for patent garden: 1. A kind of seed obtained from soybean (G/_ychema; c(L.) Merr.) a vapor fraction, which is prepared by a process comprising the steps of: (a) providing a crude extract of the seed in an alcoholic solution containing less than about 15% by weight of alcohol or water; (b) evaporating the crude extract at an atmospheric pressure of less than about 1 atm and a temperature of less than about 110 ° C to obtain the vapor fraction; wherein the inner diameter (ID) is 4.6 mm and the length (L) is 250 mm. And a 50 μl vapor fraction obtained by high performance liquid chromatography (HPLC) at a wavelength of 200 nm, with a particle size of 5 μm, including a shift factor of 8% and a hysteresis time of 2.910. The peaks of 5.190, 13.190 and 50.815 minutes, wherein the mobile phase is 95% H20/5% CH3CN for 0 to 5 minutes, 95% H20/5% CH3CN for 5 to 30 minutes, and a gradient of 30 to 80 minutes. 75% H20/25°/〇CH3CN, with a gradient of 80% to 100 minutes at 0% H20/100% CH3CN, at The gradient from 100 to 101 minutes was 0% H20/100°/〇 CH3CN, 95% H20/5% CH3CNf at 101 minutes, and the flow rate was 1 ml/min. 2. The vapor fraction of claim 1 wherein the vapor fraction is collected in liquid form by cooling vapor. 3. The vapor fraction of claim 1 wherein the concentration of the alcohol is less than about 5% wt. 4. The vapor fraction of claim 1 wherein the crude extract in step (a) is in water. 83756-940530.doc 1333420 5. The vapor fraction of claim 1, wherein the temperature in step (b) is between about 60 ° C and about 110 ° C. 6. For a patented range of g1 g of steam fraction 16, it has the treatment of skin damage, treatment of skin diseases, stimulation of cell regeneration and stimulation of hair growth.炙乍 7. A composition comprising a vapor fraction as described in the patent application. Goshen Patent | The composition of item 7, which is used in the manufacture of a pharmaceutical group, a cosmetic composition or a skin cleansing composition. 9. The composition of claim 7, which is for use in the treatment of skin damage or skin disorders. 10. The composition of claim 9, wherein the skin damage or skin condition is selected from the group consisting of burns, sunburns, radiation injuries, acute and chronic injuries, ecchymoses, dermatitis, spots, papules, nodules, blisters, large Blister, pustule, rubella, plaque, cyst, scaly disease, sputum, fissure, ulcer 'acne, dry skin, peeling, itching, allergic eczema, rash, gangrene' chronic hoarding A group of abrasions, atopic dermatitis, suture wounds, diabetic wounds, and hair follicle defects. 11. The composition of claim 9, wherein the skin damage or skin condition is selected from the group consisting of burns, radiation injuries, acute and chronic injuries, dermatitis, gangrene, chronic hoarding ulcers, abrasions, atopic dermatitis, Suture wounds, diabetic wounds, and hair follicle defects. 12. The composition of claim 7, further comprising an antibacterial agent. 3 'A composition as claimed in claim 7, which further comprises borneol, 83756-940530.doc 1333420 stearic acid, stearyl alcohol, palmitic acid, cetyl alcohol, beeswax and polyoxyethylene Sorbitan monostearate. A pharmaceutical composition for treating skin damage or skin diseases of a patient, comprising a composition effective for treating skin damage, treating skin diseases, stimulating cell regeneration, and stimulating hair growth, as in the composition of claim 7 . 83756-940530.doc
TW092122224A 2003-08-11 2003-08-11 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof TWI333420B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TW092122224A TWI333420B (en) 2003-08-11 2003-08-11 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof
KR1020040063087A KR101284071B1 (en) 2003-08-11 2004-08-11 Vapor fraction from seeds of glycine max(l.) merr. and composition thereof
KR1020110040816A KR101220124B1 (en) 2003-08-11 2011-04-29 Vapor fraction from seeds of glycine max(l.) merr. and composition thereof
KR1020120056185A KR101252023B1 (en) 2003-08-11 2012-05-25 Vapor fraction from seeds of glycine max(l.) merr. and composition thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW092122224A TWI333420B (en) 2003-08-11 2003-08-11 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof

Publications (2)

Publication Number Publication Date
TW200505466A TW200505466A (en) 2005-02-16
TWI333420B true TWI333420B (en) 2010-11-21

Family

ID=37230929

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092122224A TWI333420B (en) 2003-08-11 2003-08-11 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof

Country Status (2)

Country Link
KR (3) KR101284071B1 (en)
TW (1) TWI333420B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948847A (en) * 2014-05-18 2014-07-30 黑龙江八一农垦大学 Traditional Chinese medicine composition for treating non-gonococcal urethritis and preparation method thereof
US10543243B2 (en) 2016-06-06 2020-01-28 Charsire Biotechnology Corp. Soybeam seed extract, method for producing the same and uses thereof
KR101884221B1 (en) * 2017-06-02 2018-08-01 차사이어 바이오테크놀로지 코포레이션 Soybean seed extract, method for producing the same and uses thereof
CN112022792B (en) * 2020-09-27 2022-12-09 黑龙江省中医药科学院 Preparation method of edible traditional Chinese medicine hair dye with homology of medicine and food

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921364A (en) * 1982-07-29 1984-02-03 Ajinomoto Co Inc Preparation of soybean or soybean protein having improved quality
US6248910B1 (en) * 1991-12-31 2001-06-19 University Research & Marketing Inc. Process for extracting oil from oil-bearing naturally occurring organic materials
JP2000169347A (en) 1998-12-10 2000-06-20 Junsai Bun Hair tonic
KR100370455B1 (en) * 2000-05-19 2003-01-29 황상민 Cosmetic composition for dry skin of atopic dermatitis and recovery of disrupted skin barrier
KR100361040B1 (en) * 2000-10-05 2002-11-23 주식회사 코리아나화장품 Skin care composition containing stabilized phellodendri radix, macrocarpium dfficinale, rheum coreanum, prunus ansu, angelica gigas, eugenia caryophyllata, imperata cylindrica with niosome

Also Published As

Publication number Publication date
KR101220124B1 (en) 2013-01-11
KR20120081046A (en) 2012-07-18
KR20110050613A (en) 2011-05-16
TW200505466A (en) 2005-02-16
KR101252023B1 (en) 2013-04-08
KR101284071B1 (en) 2013-07-10
KR20050023196A (en) 2005-03-09

Similar Documents

Publication Publication Date Title
KR101762750B1 (en) Cosmetic composition for skin cell regeneration and wound healing the use there of containing absolute of Hibiscus syriacus L.flower
US20190151232A1 (en) Topical Compositions, Process of Manufacture and Method of Use
KR102083294B1 (en) A composition for skin reproduction containing extracts of abeliophyllum distichum and extract thereof having skin reproduction effect
Li et al. Evaluation of effectiveness in a novel wound healing ointment-crocodile oil burn ointment
WO1999038479A1 (en) Banana peel extract composition and method for extraction
JP4681218B2 (en) Volatile fractions and compositions from soybean seeds
KR101252023B1 (en) Vapor fraction from seeds of glycine max(l.) merr. and composition thereof
CN110974861B (en) Blumea balsamifera oil liposome
US7112344B2 (en) Vapor fraction from seeds of Glycine max (L.)Merr. and composition thereof
EP4153321A1 (en) Topical compositions, process of large-scale manufacture, and method of use
CN100411638C (en) Steam distillate from soybean and its composition
IL261123A (en) Herbal topical composition for muscle and joint health, recovery from exertion, and for pain management
US7282226B2 (en) Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof
CN113925907A (en) Antibacterial anti-inflammatory and antiallergic composition as well as preparation method and application thereof
CN113876852A (en) Antibacterial anti-inflammatory and antiallergic composition as well as preparation method and application thereof
EP1506782B1 (en) Vapor fraction from seeds of glycine max (L.) merr. and composition thereof
US20200061144A1 (en) Composition and Method of Skin Relief Cream useful for Eczema, Psoriasis, Lipoma, Burn Wounds, Scars, Keloids, Shingles, Dry Skin Disorders, and Skin Allergies.
AU2003231713B2 (en) Vapor fraction from seeds of glycine max (L.) Merr. and composition thereof
CN108524886A (en) A kind of tinea of feet and hands drug paste and preparation method thereof
TW200534862A (en) Vapor fraction from seeds of glycine max (L.) merr. And composition thereof
TW201309317A (en) An extract of plant providing for treating the healing of wounds
CN108186818B (en) Plaster for softening and removing cutin and preparation method thereof
KR101938360B1 (en) Composition for enhancing and maintaining skin permeability
Abd et al. Study of the effect of cytotoxicity of extracts from Origanum Majorana leaves on human breast cancer cell line (AMJ13) in vitro
CN117064987A (en) A pharmaceutical composition for treating traumatology, and its preparation method and application

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent